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(3-(Aminomethyl)-4-chlorobenzenepropanoic acid (Baclofen), 3-(p-chlorophenyl)-
pyrrolidone (Baclofen lactam) and 3-(p-Chlorophenyl)glutaramide (baclofen's synthetic 
precursor) were individually used as substrates in co-crystallisation experiments with 
several resolving agents. Experiments were conducted in the solid state and in solution. The 
(-) enantiomer of the lactam and the ( +) enantiom~r of the glutaramide were found to co-
crystallise selectively with (2R,3R)-( +)-tartaric acid and (S)-(-)-a.-Methylbenzylamine 
respectively. Both these dissociable diastereomers \Vere analysed by X-ray 
crystallography. HPLC analysis of the lactam retrieved from the former co-crystals 
indicated only partial separation of its (+) and (-) enantiomers. X-ray crystallographic, 
thermal, and polarimetric analyses were perfom1ed on the ( + )- and (-)-salts of the latter 
co-crystals. The solubilities of these salts in methanol were found to differ by a factor of 4. 
A solubility diagram was established showing the phase equilibria of various ratios of 
these two salts in methanol. The(+) enantiomer of the glutaramide was separated from the 
methylbenzylamine in the (+) salt by treatment with HCI. This enantiomer was converted 
to (R)-(-)-Baclofen by means of a Hofinann Rearrangement with an overall yield of 40%. 
The enantiomeric excess of (R)-(".")-Baclofen was 99.7%. 
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Author's Note 
There are three systems by which the absolute configuration of enantiomers are designated: 
1. Fischer Projection: This is the oldest system by which the absolute configuration of a 
particular enantiomer is designated D or L (as indirectly related to the enantiomers of 
glyceraldehyde). Today this system is no longer used, except for certain groups of 
compounds such as carbohydrates and amino acids. 
2. Cahn-lngold-Prelog System: This has replaced the DL system. The four groups on an 
asymmetric carbon are ranked according to a set of sequence rules. The asymmetric centre 
is then designated R or S accordingly. 
3. Optical rotation: A practical method of referring to particular enantiomers of chiral 
compounds is by assignment of the letters d or /. This simply refers to the direction in 
which the enantiomers rotate the plane of polarized light. The dextro isomer rotates the 
plane clockwise and is designated (+), while the /evo isomer rotates the plane 
counterclockwise and is designated ( -) . 
The Author is aware that the three systems are in no way interrelated. In this thesis the 
absolute configuration of particular enantiomers are designated in accordance with the 
publications reporting their resolutions or other related studies. The enantiomers resolved 
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1.1 Chiral Drugs 
The biological activity of drug racemic mi>..1ures rests in most cases r one of the two antipodal 
isomers (enantiomers), and the other is an undesired commodity. Chiral drugs are therefore of 
growing interest, due to their higher selectivity in biological action and greater potency than the 
corresponding racemic mixtures 1• Pharmaceutical industries are accepting the dogmas that 
racemic mixtures should first be resolved and only the active enantiomer be further 
investigated. Enantiomers display different pharmacokinetics, are metabolised differently by 
enzymes, and have quite different toxicities. The Thalidomide disaster in the early 1960's is 
perhaps the most vivid example of the importance of stereochemistry in drug molecules2. 
(S)-(-)-TI1alidomide is a powerful tranquilliser whereas (R)-( +)-Thalidomide can disrupt fetal 
development, causing severe handicap. Developed by the West German firm of Chemie-
Gruenenthal just after World War II, the drug was finally withdrawn from the market in 
December 1961. By then, as a consequence of specific recommendations by the makers that 
Thalidomide be used in pregnant women, some 8 - 9000 babies were born with horrible 
deformities. Preparation and testing of both enantiomers, although cos~ly, is therefore vital. 
This form of careful research may lead to nvo medically useful agents such as the antipodes of 
the optically active Tetrahydrocannabinols HU-210 and HU-211. 
HU-210 HU-211 
TI1e former shows potent psychotropic activity, \\•hile the latter is an antiemetic3 . 
It therefore suffices to mention that a wide variety of examples of differing medicinal uses of 
enantiomorphous antipodes exist, and that single enantiomeric drugs constitute 20% of the 
world's 95 best selling drugs4. Kooreman of International Biosynthesis in the Netherlands 
predicted that more than .50% of the manufactured drugs would be chiral by the end of the 
century1• 
This leads to the drug under investigation in this project, viz. Baclofen (P-(Aminomethyl)-4-
chlorobenzenepropanoic acid, hereinafter BC). 
BC 
Sold under the trade name Lioresal, the drug is presently still marketed as the racemate. The 
biological activity and physical properties of the racemic drug are well documented in the 
literature5•6. Further e:>..'tensive pharmacological tests have concluded that the biological activity 
of this skeletal muscle relaxant resides with the l-enantiomer7. Later studies by Hill and Bowery 
confinned that this enantiomer was indeed 100 times more active than the d-enantiomer8. Hence 
there is a need for an effective and. simple r€solution method. 
1.2 Resolution Methods. 
There are two broad categories of methods for enantiomeric purification: Resolution, and 
stereoselective synthesis. Although previous enantiomeric purifications of baclofen have made 
use of the latter method (see section 1.3.1), our present survey will only be dealing with the 
former category. By definition, a resolution is the separation of a racemate into its enantiomer 
constituents. In resolution methods, the point of depart.ure is the racemate implying that a 
maximum yield of only 50% can be attained. Under this broad category, several resolution 
methods are now widely used: 
The oldest resolution method is the direct crystallisation of enantiomers from solutions of 
racemates in the absence of resolving agents. This may be enhanced by seeding the 
supersaturated solutions of the racemates to initiate preferential crystallisation. The theory 
thereof is well established9 and fonns a fascinating yet simple resolution teclmique. The major 
prerequisite (and therefore restriction) is that the racemate must be a conglomerate under the 
conditions of crystallisation. An industrial scale resolution of the Chloramphenicol base (Sect 
3.1 compound 20) developed by Amiard and co-workers 10 uses this method. The racemate is 
seeded with the (-) enantiomer causing conglomerates of this enantiomer to crystallise out 
preferentially. Further resolution methods are the following: Resolution via the formation of 
Dissociable or Covalent Diastereomers, Resolution via Chiral Liquid or Gas Chromatography , 
Kinetic Resolutions and Resolutions via Host-Guest Chemistry. 
3 
1.2.1 Dissociable Diastereomers. 
The largest number of recorded resolutions have been effected by conversion of a racemate to a· 
mixture of diastereomers. In this type of reaction the substrate that is to be resolved is treated 
with one enantiom~r of a chiral substance. 
1.2.1.1 Diastereomeric Complexes. 
Although less common, diverse addition compounds do exist and have in common their ease of 
usage. Examples of dissociable crystalline combinations are Lewis acid-base complexes, 
inclusion compounds and quasi-racemates. Resolution of compounds devoid of acidic or· basic 
functionality can in principle be resolved by this method. Aromatic amines whose chirality 










have been resolved by the fomrntion of 7t-complexes with 





BC, when heated above 180°C degrades to fonn a Lactam (3-(4-chlorophenyl)pyrrolidinone) 
hereinafter BC-Lac'~. 
BC-Lac 
This compound, being a substrate similarly devoid of both strong acidic or basic moieties, can 
therefore in theory only really be separated by means of the above discussed interaction, if a 
suitable resolving agent were to be used. 
4 
1.2.l.2 Diastereomeric Salts 
Resolution via diastereomeric salt formation is widely used industrially and in particular 
furnishes a large proportion of those optically active drugs which are not derived from natural 
products13 • A study conducted in a representative group of such drugs showed that 65% owe 
their optical activity to this classical resolution method14. An excellent review exists, provided 
by Wilen et al 15, describing systematic strategies in optical resolution via diastereomeric salt 
formation. Despite the technique being sometimes viewed as owing too much to empiricism to 
be worthy of serious consideration, this review provides a rational approach for resolving 
organic compounds bearing acidic or basic functional groups. 
The method utilising the formation of a salt between a racemic acid and an optically active base 
was discovered by Pasteur in 1853 16. The process may be summarised by the following scheme 
(symbols A and B represent an acid and base respectively). 
di-A + 1-B d-A.l-B + /-A./-B 
racemate resolving agent n-salt* p-salt* 
The salts formed are diastereomers with differing physical properties and may be separated in a 
number of ways, for example by chromatography. The most efficient way of separating such 
salts is by crystallisation. The latter method relies on the differing solubilities of the two 
diastereomeric salts and is the key that governs their separation. The greater the solubility 
difference of the n:vo diastereomers, the greater the ease with which resolution can be effected. 
Solubility differences can be substantial. Some examples follow in Table l. l: 
Table 1.1: (Solubilities are in g/lOOg solution) 
Acid Base Solubilitv Solvent T(°C) 
p salt n salt 
2,2 '-dihydroxybinaphthyl-3,3 '-dicarboxylic acid Leucine 0.44 IOI Methanol 28.5 
6,6' -Dinitrodiphenic acid a-Methylbenzylamine 0.61 13.0 Acetone 30 
Mandelic Acid Ephedrine 6.0 77.48 Water 25 
Mandelic Acid a-Methylbenzylamine 23 4.0 Ethanol 10 
Mandelic Acid a-Methvlbenzylamine 18 4.9 Water 30 
Hydrntropic Acid a.-Methylbenzylamine 4.8 6.4 Ethanol 10 
Mandelic Acid Propadrine 6.08 7.70 Water 25 
• This convenient nomenclature derives from a proposal made by Ugi 17 where p refers to the 
salt in which substrate and resolving agent are of like sign and n to the salt in which substrate 










Among the physical properties of Diastereomeric salts, such as crystal structure (to be 
discussed in more detail in Chapter 4), density, melting points and enthalpy of fusion, the above 
listed solubility differences are perhaps the most indicative of separation effectiveness. Salts 
such as the 2,2 '-dihydroxybinaphthyl-3,3 '-dicarboxylic acid I Leu cine diastereomers show such 
considerable solubility differences between the p and n salt~, that primary enrichment may 
easily be effected by "washing off' the more soluble n salt with methanol. Where the 
solubilities differ to a lesser extent, optimal crystallisation conditions for diastereomerically 
pure recoveries (such as temperature and concentration), are more difficult to establish. The 
solubilities of a three component system (two diastereomers and a solvent) may be rationalised 
in terms of a ternary phase diagram. 
Solubility Diagrams of Diastereomeric Salt Mixtures: 
Leclercq et al. 
21 
provide one of the few experimentally detem1ined solubility diagrams. 
Particularly in the case of industrial resolutions where optimisation is economically justifiable, 
such investigations may lead to the desired improvement. 
A solubility diagram (Figure l. l) describes .the solubility of each diastereomer in pure solvent 
(points a and b) and of diastereomer mixtures in the same solvent (isotherms ae and be). For 
many organic mix'tures the eutectic composition (point c) is practically independent of 
temperature
23
. This implies that at lower temperatures, parallel isotherms (a'e' and b'e') 
similarly yield the composition of the satUrated solutions of all possible mixtures of P and N 
salts. Assuming the salts to be unsolvated, four significant regions in the phase diagram can be 
defined: 
D: P and N salts both unsaturated. 
A: Pure Pis in equilibrium with solvent containing dissolved P and Nin proportion 
described by the ae isotherm. 
B: Pure N is in equilibrium with solvent containing dissolved P and N in proportion 
described by the be isothenn. 
C: Saturated solution of fixed composition (composition c) in equilibrium with solid P and 





Figure 1.1: Ternary phase diagram ofunsolvated salts. 
A typical separation experiment will therefore start with an·unsaturated solution of composition 
m (i.e. I: 1 n:p ratio) which would be represented on the diagram by point f. As the solvent 
evaporates and the solution is concentrated, point f descends along the tie line to point g where 
the less soluble P salt becomes saturated and crystallisation of pure P conu11ences. Further 
evaporation (point h) will still yield pure crystalline P in equilibrium with the mother liquor of 
composition 1. Below tie line Pe the more soluble N salt commences to crystallise. 
"Overshooting" the crystallisation to point i would therefore yield a mixture of crystalline P 
and N salts in equilibrium with a mother liquor of eutectic composition. 
These Phase Diagrams are somewhat complicated by the follmving: 
(a) Fom1ation of solvated salts. This usually causes isothen11s ae and eb to deviate from 
linearity. 
(b) Formation of solid solutions. The purity of the diastereomer obtained in such a separation 
process depends upon the possible existence of a solid solution at the extremities of the diagram 
and upon their relative importance. (Figure 1.2). 
7 
s 
N +- ---+ p 
Figure 1.2: Solid solutions at the extremities P and N of the diagram 
(c) Formation of double salts. Partial resolution is still possible when double salts [px, ny] form 
where x ;;t; y. However, the optical purity attainable cannot exceed that which may be deduced 
from the stoichiometry of the salts. 
Generally, the further away point c (eutectic composition) lies from point m (racemic solution), 
(Figure 1.1), the greater the ease of separation and the higher the yield per crystallisation. 
1.2.2 Host-Guest Chemistry 
1.2.2.1 In solution 
This resolution methodology is particularly useful for those compounds devoid of any 
conventional functionality (e.g., chiral alkenes and arenes, sulfoxides and phosphines). 
Inclusion of molecules within others is a widespread phenomenon and is finding increasing 
application in resolutions. Some excellent reviews cover this growing topic24•25 . With the host 
compounds being chiral, preferential inclusiori of one substrate enantiomer can occur as a 
result of selective hydrogen bonding and van der Waals attraction between guest and host 
molecules. Subsequent separation of the diastereomeric inclusion compound may involve 
melting, dissolution, or extraction of the enantiomerically enriched guest. Resolution therefore 
depends on differential solubility or stability. A limitation of this technique is that the relative 
size and shape of the guest molecule must match the size and shape of the chiral cavity created 
by the host molecule (resolving agent). The cavitates are large host compounds, such as 
cyclodextrins, and have cavities that may partially or entirely envelop the resolution substrate. 
Sin1ilar cavities can result from the assemblance of several chiral host molecules forming a 
cage or cham1el. These are often called clathrates. More often than not these chiral hosts 
8 
require resolution prior to their use in resolutions. To circumvent this problem in this study, ·a 
host was chosen that itself derives from enantiopure diethyl (2R, JR)-tartrate (made from 
natural tartaric acid), VIZ. trans bis(hydroxydiphenylmethyl)-2,2-dimethyl- l ,3-
dioxycyclopentane 1 and similar derivatives 2 and 3. 
Ph 
CH) 




0 ):X) R.........._ 2 R= 0 H 
Ph OH 3 R= 0 
Ph 4 
1 has been effectively applied to the resolution of racemates such as the Wieland-Miescher 
ketone 4
26
.Compounds 1 - 3 are extremely effective in resolving some neutral compounds that 
are otherwise difficult to resolve. 
1.2.2.2 In the Solid State. 
Alternatively, the host-guest complexes can be forn1ed by grinding together solid guest and host 
reaction partners. Often, the physical conditions needed for the latter reactions to take place, 
i.e. high temperatures and pressures, are generally too insensitive and uncontrolled to allow for 
effective solid state chiral discrimination. Despite this, bypassing the slow process of 
crystallisation from solution and alleviating the often confronted problem of included solvents 
seemed important enough to undertake particular solid state experiments with the drug in 
question. Supportive of this novel teclmique are recent indications in the literature that. 
crystalline hosts _such as 1 and 2, when suspended in hexane or water, forn1 the same inclusion 
compounds with chiral guests as in solution27'28 . This suspension technique is more selective 
and effective than the initially developed solution technique. Racemic alcohols, fi-hydroxy 
esters, epoxy esters and epoxy ketones, such as compounds 5 - 8, were stirred for a few hours 
with appropriate hosts (suspensions of 1, 2 and 3) and forn1ed 1: 1 complexes that could be 
isolated in yields> 85% and with ee· values> 97%. Thus a crystal/liquid reaction occurs. This 
is probable because the solid-state inclusion complexation has been proven to occur by simple 
shaking of a mixture of powdered host and guest compounds29. 
0 
H H 
Et C02Et 60 I I Ph-C-Me Me-C-CH2C02Et EtVH I I 
OH OH 0 ' 
5 6 7 8 
• Where a racemic compound is resolved into its R and S enantiomers, we define the percent 
enantiomeric excess (ee) as ([R] - [S])/((R] + [S]) x 100 = %R - %S. 
9 
fa .. 1ending these possibilities to solid-solid reactions bet\veen host and guest (resolving agent 
and substrate) therefore seemed an exciting prospect in the present study, especially in view of 
recent successful solid-solid reactions discovered in our own laboratory3°. Concerning the 
current project, preliminary interests were therefore merely to test whether any diastereomeric 
association could result from co-grinding a powdered resolving agent with a powdered racemic 
drug. This in itself proves to be a unique field of research, since the intricate processes involved 
in co-operative hydrogen bonding arrangements and solid state phase transformations are as yet 
poorly understood. 
1.3 Bacio fen. 
Baclofen is synthesised from 4-chlorobenzaldehyde as indicated in the scheme below: 
· CO H 
CHO lf=~ONH2 
4 steps"' I 







The drug's synthetic precursor, 3-(p-Chlorophenyl)glutaramide (hereinafter GAM), is 
converted to baclofen by means of a Hofmaim Rearrangement. The reaction proceeds under 
relatively mild conditions and absolute configuration is retained during the reaction31 . The 
preparation route is covered by two separate patents.32•33 
Baclofen is used clinically for the treatment of spasticity of spinal and cerebral origin34. It was 
synthesised as a possible y-aminobutyric acid (GABA)-mimetic which could readily gain 
access to the brain after oral administration. The drug appears to have stereospecific actions on 
the peripheral and central nervous systems. As previously mentioned, the enantiomers of this 
compound differ in their_ phannacodynamic and toxicological properties; the (-) enantiomer is 
much more active but also more toxic than the (+) enantiomer. The R configuration was 
assigned to the more active enantiomer on the basis of X-ray crystallography35 . 
1.3 .1 Previous Resolutions 
The above mentioned selective activities led to extensive research concerning methods of 
separating the optical isomers of Baclofen. Several methods of resolution have since appeared 
in the literature. These are mainly Chromatographic separations, making use of either b.onded 
chiral stationary phases, or mobile phases with chiral modifiers. Other methods include 
10 
Asymmetric syntheses as well as a Chemoenzymatic synthesis. Here follows a brief 
chronological account of the more interesting separations reported in the literature thus far: 
Chromatographic separations. 
i) Analvtical 
(1) An HPLC (reverse-phase) enantioselective detem1ination of the dmg by making use of 
pre-column derivatisation with an o-phthaldialdehyde · - N-acetyl-L-cysteine (OPA-NAC) 
reagent36. 
(2) Separation of baclofen's corresponding Lactam, BC-Lac, by Chiral Liquid 
Chromatography using imn10bilised bovine semm albumin as the stationary phase. 
Baclofen showed little retention and no resolution37. 
(3) An enantioselective crown ether HPLC colunm was used to separate Baclofen and 
analogues. Perchloric acid with methanol as organic modifier was used as mobile phase. 
The best results were obtained with Baclofen (Cl= 1.48; Rs= 8.07)38 . 
(4) Separation on a J3- or a y-cyclodextrin-bonded silica column after pre-colunm fluorescence 
derivatisation \vith o-phthalaldehyde or 2,3-naphthalenedialdehyde in the presence of thiols 
"d 39 or cyam e . 
Other variations of analytical procedures for the detection of R and S enantiomers in different 
environments exist. An example is the detection of the enantiomers in blood plasma and urine 
by gas chromatography using a chiral fused-silica capillary colunm and an electron-capture 
detector40. 
ii) Preparative 
(5) A three-step separation involving a reverse-phase (C 18) HPLC column usmg a chiral 
mobile phase of aqueous copper (II) acetate and N,N-di-n-propyl-L-alanine (DPA) diluted 
with acetonitrile. Subsequent breaking of the copper-DPA-baclofen complex was 
perfom1ed by retention of copper ions on a cation-exchange column. Baclofen was 
separated from DPA by reverse-phase HPLC using 70% MeOH/water as the mobile 
phase41 . 
(6) A diastereomeric mixture separation of Baclofen after derivatisation by protection of the 
amino group with di-tert-butyl carbonate and reaction with (S)-a.-methylbenzylamine. The 
RS and SS diastereomers 9 were successfully resolved by Chromatography carried out on 
silica gel employing n-hexane-ethyl acetate as eluent42 . 
11 
Clo ~ I~ CH I~







(7) Facile access to (R)-Baclofen was provided m a five-step synthesis starting from 
(S)-pyroglutamic acid derivative 10 \vith an overall yield of 16%43 . This synthesis was 
subsequently optimised and patented by using a different Grignard reagent in the 1,4-
conjugate addition to 1044 . 
10 
(8) The Chiral Imide 11 (R = H) was alkylated via its imide enolate with BrCH2C02CMe3 
Removal of the chiral auxiliary from intem1ediate 11 (R = CH2C02CMe3) provided a 
lactone. This was transfom1ed to give the Lactam (BC-Lac) which yielded (R)-Baclofen 
after acidic hydrolysis45 . 
11 
Chemoenzymatic synthesis: 
(9) Tv.10 approaches are used in the enantioselective syntheses of Baclofen based on the 
distinction between enantiotropic ester groups in compounds bearing a prochiral centre. 
The first involved the key step of highly stereoselective enzymatic hydrolysis of 12 by 
Chymotrypsin. In the second, the key step was the enzyme-catalysed esterification of 13 by 









1.4 Resolving Agents. 
Today, numerous enantiomerically pure compounds are conunercially available that may be 
useful as asymmetric building blocks, for use as chiral auxiliaries or as resolving agents. No 
attempt shall be made to present an exhaustive list of resolving agents and their specific fields 
of application. A variety of optically pure amino acids, hydroxy acids, carbohydrates and their 
derivatives, terpenes and alkaloids are now readily available. The choice of resolving agent 
relating to the fom1ation of diastereomeric salts and subsequent crystallisation is not trivial. 
Looking at any of the molecules such as GAM, BC or BC-Lac, one could in theory choose 
suitable acids or bases, according to the substrate's functionality, with which to conm1ence 
experimentation in a suitable solvent. One searches for: 
(1) diastereomeric salts that crystallise well and show suitable differential solubility between 
the diastereomeric pairs. 
(2) Ease of salt fonnation and subsequent recovery of the individual components. 
(3) Inexpensive resolving agents. 
(4) Resolving agents that are available in optically pure form. 
(5) Substrates and resolving agents whose chiral centres are not too remote from the 
functionality with which salt fonnation is to be effected. 
(6) Chemically stable agents that do not racemise. 
(7) The availability of both enantiomers of the agent. 
With the above considerations and bearing in mind the aforementioned functional groups 
present in our substrates, the literature provides some encouraging infonnation. Amino acids 
are most often resolved in '"protected" fonn, mainly via derivatisation of the amino group to 
yield for example N-acetyl or N-benzyloxycarbonyl compounds that may be resolved ''vith an 
optically active base47 . a-Methylbenzylamine (MBA) is a common basic (pKb = 4.5) resolving 
agent easily regenerated and purified after use via its sulphate48 . MBA was found useful in the 
separation of a GABA analogue P-Phenyl-y-aminobutyric acid. This drug, differing from 
Baclofen in the absence of the p-chloro substituent is used as a mood elevator and 
tranquilliser49 . The resolution was effected by fractional crystallisation of the N-
carbobenzyloxy-protected racemate 14 with MBA50 or Cinchonidine51 • Protection of the. 
primary amine yielded an exposed acidic moiety, similar to the functionality of GAM, with 
which salt fonnation could be effected. 
13 
14 
Further protection by diastereomeric ester formation has been applied to the resolution of the 
N-phthalimido derivatives of GABA analogues (15) by using the alcohol protected sugar 
Ribonolactone 1652 . 
HO 0 
PhtN"UC02H ~o '"'"' °* 
0 oxo 
15 16 
The trans-(+)-(IR,4R)-phthalimido ester was crystallised out of a solution of pyridine and 
tetrahydrofuran. The direct resolution of free amino acids ·is obviously a more attractive 
process than that involving prior introduction and subsequent cleavage of a protection group. 
Strong acidic resolving agents are sometimes capable of fanning , with neutral, unprotected 
amino acids, nicely crystalline salts that are analogous in nature to amino acid hydrochlorides. 
DL-phenylglycine53 and Terleucine54 have been efficiently resolved with 10-Camphorsulphonic 





/ " 0 OH 
2,2'-(l,l '-binaphthyl)-phosphoric acid 17 is a strongly acidic resolving agent (pK. = 2.50). The 
racemate of 17 is resolved with cinchonine to afford pure (S)-( + )-17, and with cinchonidine to 
afford pure (R)-(-)-1757• The enantiomers of this acid fonn well crystallised salts with a wide 
variety of organic bases, and therefore represent a useful tool for the res~lution of amines58•59 . 
The subsequently designed anologue (18) h~s also proved to be useful for the separation of 
amines and amino acids60 . 
14 
18 
Among the natural optically pure resolving agents, tartaric acid probably has the longest 
history within organic stereochemistry. Industrially it finds its use mainly as a resolving agent 
rather than as a chiral building block. Being a "bi-acid" it is effective in resolving dian1ines for 
example61 . The acid's abundance and availability make it an attractive agent for 
experimentation. Several resolving agents are derivatised from the acid, such as compounds 1-
3, di-p-toluoltartaric acid and 0, 0-dibenzoyltartaric acid. This latter derivative, for example, 
was used in resolving the methyl ester of Terleucine ((CH3)3CCH(NH2)COOH)
62
. 
Numerous other possible agents could be discussed in speculating. what may be the correct 
choice of resolving agent for the resolution of Baclofen. The objective of this project was to 
produce optically pure (R)-(-)-Baclofen by either resolving the racemic dmg itself, by resolving 
its synthetic precursor GAM, or even by trying to separate the BC-Lac and hydrolysing the 
enantiopure Lactam ''vi th HCl to give the desired product 63 . 
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2. METHODS AND MATERIALS 
2.1 Starting Materials. 
2.1.1 Substrates. 
Both BC and GAM were kindly supplied by Fine Chemicals Corporation, Eppindust, South Africa. 
BC-Lac was synthesised by simple cyclodehydratiori of BC. Several synthetic methods optimise 
lactam production from y- or 5-amino acids 1 A simplistic approach is to keep BC at the melting 
temperature (205°C) for a few minutes2. Upon cooling, instant resolidification occurs. Completion 
of the thermal decomposition or rearrangement to the y-lactam may be checked by TLC (precoated 
silica gel 60 F 254 plates. Mobile phase: isopropanol: acetic acid: water (70: 15: 15)). The lactam 
is then purified by two recrystallisations from toluene:hexane (90: 10) (m.p. l 18°C). 
This method was subsequently improved by refluxing in toluene I acetic acid. 30 ml acetic acid 
was added to a stirred suspension of 8.230g BC in 300 ml toluene and refluxed for ca two hours. 
The progress of the reaction was followed by TLC (chloroform: ethyl acetate 70:30 on silica). The 
reaction mix'ture becomes clear with time as the lactam is soluble in this solvent mixture. The 
solution was filtered to remove any unreacted BC and the solvent removed by using a rotary 
evaporator. The remaining acetic acid was removed by redissolving the product in 100 ml toluene 
and the solvent again removed under vacuum. 
2.1.2 Resolving Agents. 
The following resolving agents were at our disposal for experimentation with the drug and the 
analogues as discussed above: (abbreviations used hereafter follow in parentheses) 
Acids 
L-(+)-Tartaric Acid 
L-(+)-Tartaric Acid Dimethyl Ester 
L-(-)-Tartaric Acid 2,3-Dibenzoyl Ester 
D-(-)-10-Camphorsulfonic Acid 
L-(-)-Mandelic Acid, D-(+)-Mandelic Acid 
L-(-)-Malic Acid 
Bases 

















trans-4 ,5-bis(hydrox·ydi phenylmethyl )-2 ,2-dimethyl- l, 3-dio~acyclopentane (HMD 3) * 
(R,R)-(-)-trans-2,3-bis(hydrox·ydiphenylmelhyl)-l,4-dioxaspiro[4.4]nonane (HMD5)* 
1 (R,R)-(-)-trans-2,3-bis(hydroxydiphenylmethyl)- l, 4-dioxaspiro[ 5. 4 ]decane (HMD6 )* 
\ 
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Some of the alkaloids were also available as their sulphate or chloride salts. In th~ interest of 
j . . . . 
diastereomeric $alt formation' these were generally avoided. 
Synthesis of (R)-(-)-J. l '-Binaphthyl-2,2 '-Diyl Hydrogen Pho"sphate ((R)-(-)-BNP Acid) 
Procedures for the synthesis of BNP acid have been reported in the literature3•4•5•6 . The acid is 
f successfully resolved with either CIND or CIN, but has more recently been resolved with (RH-)-2-
am.inobutan~I7. The general procedures (shown in the scheme. below).of Jacques .and Fouquey were 
adopted and modified
4
. Subse{iuent literature values quoted for optical rotational values etc. refer 










0 0 Resolution 
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To a stirred suspension of4g (14 mmol) (±)-1,1 '-bi-2-naphthol in 18 ml pyridine, was added 1.78 
ml ( 19 .2 mmol) of freshly distilled phosphorus oxychloride by slow dropwise injection. The 
*These hosts are sketched on page 8 of Chapter I (compounds l,2 and 3). 
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temperature of the solution ';vas allowed to rise to ca 80°C to allow for complete dissolution. The 
solution was cooled to 65°C at which temperature crystallisation occurred. To the stirred 
suspension was added 2 ml water raising the reaction temperature to 120°C. The solution was 
allowed to cool to 60°C and was slowly added to 36 ml of 6 M HCl, whilst vigorously stirring. The 
resulting pyridine solvated BNP acid was collected by suction filtration and the wet cake added to 
and stirred with 12 ml 6 M HCI. The solid was thoroughly filtered off at the pump, washed with 
water and air dried to afford 4.32g (90%) of (±)-BNP acid. This product decomposed slowly at 
about 300°C without melting (as quoted in literature). 
4g (±)-BNP (11.3 mmol) acid and 3.37g (11.3 mmol) Cinchonidine were dissolved in 50 ml hot 
(60°C) methanol. To the hot solution was added ca 10 ml hot water dropwise over a period of 
about 30 min. During this time the solution was stirred and maintained at this temperature. The 
solution was kept sufficiently dilute in order to prevent fast crystallisation. The diastereomeric salt 
mixture was then allowed to cool, affording 1. 84g of colourless crystals of the p salt [ ( -)-acid, ( -)-
base] after ca 24 hours, [a0 ]s89 = -390° (methanol), m.p. 240°C (slow melt). 
1.5 g of the above salt ·was dissolved in 10 ml ethanol by heating to reflux. To this solution was 
slowly added 11 ml of 6 M hydrochloric acid whilst stirring vigorously and maintaining the 
temperature at 80°C. Precipitation of the BNP acid commenced immediately upon cooling. The 
solid was collected and washed with water and air dried to afford 0.72 g of (R)-(-)-BNP acid, 
[a0 ]s89 = -590° (Lit. -595°). The acid decomposed above 300°C. 
2.2 Diastereomeric Salt Formation. 
As a consequence of the numerous experiments carried out in attempts to primarily effect some 
fonn of association betvveen the drug molecules and one enantiomer of a chiral resolving agent, 
general procedures of typical resolution experiments are outlined in sections 2 .2 .1 and 2 .2 .2. 
Further details on a fev.1 of the more successful experiments will be discussed in Chapter 3. 
21 
2.2.1. Salt Formation in Solution. 
Approximately 10-3 mole (normally of the order of 100 - 150 mg) of the racemic substrate were 
combined with an equivalent amount of optically active base or acid. These were then dissolved in 
a quantity of a suitable solvent (ca 4 - 5 ml). A statistical analysis of solvents used in over 800 
resolutions involving formation and separation of diastereomeric salts showed that alcohols and 
acetone (anhydrous or aqueous), water, and mixtures of solvents containing an alcohol figure in 
about 90% of the cases8. In our experiments the following solvents were used (this was also subject 






·Methanol, ethanol with acetone or ethyl acetate as precipitants. 
Same as for GAM as well as benzene or toluene with hexane as precipitant. 
The drug is poorly soluble in almost all organic solvents. BC is soluble in acidic 
or basic solutions. Dissolution in solutions of acidic or basic resolving agents 
were only partially successful. 
Crystallisation experiments were set up in 10 ml vials. Complete dissolu~ion was accomplished by 
gentle wam1ing to 40 - 60°C (boiling was avoided). Crystallisation ''vas induced by one of ilie 
following techniques: 
1) Slow evaporation: Dilute solutions vvere allowed to stand for 24 hours (sometimes several 
days). Should the system lend itself to preferential crystallisation of one diastereomer, this 
technique avoided overshooting the concentration to that of region C on the phase diagram 
(Figure 1.1, section 1.2.1.2). 
2) Slow cooling: In tenns of the phase diagram, this technique differs from the latter in tlmt 
isothem1s ae and eh are "lowered" from their equilibrium position such that complete 
dissolution may take place. Crystallisation is then induced by allowing gradual return ("rising") 
of the isothenns (i.e. gradual cooling). Concentration is therefore static and must carefully be 
chosen such that it lies within region A. This was therefore only possible once salt formation 
was confirmed. 
3) mixed solvents: Where single solvent systems rendered inadequate solubility differences 
between diastereomeric pairs, the solvents were modified by the additipn of a second (or even a 
third) solvent, to alter the polarity, density, and viscosity of the system. In effect this may alter 
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the position of a eutectic or even reverse the relative solubilities of the p and n salts. In the 
resolution of 2,2-Dimethyl-3-phenylpentanoic acid with quinine for example9, the (+) 
enantiomer was retrieved from the less soluble salt when crystallised from ethanol whereas the 
use of aqueous ethanol rendered the salt containing the (-) enantiomer less soluble due to 
salvation. Dual solvent systems proved to be imperative where substrate and resolving agent did 
not have a common solvent. In the latter case combination of the acid base pairs would be 
effected by separate dissolution of the two components and subsequent combination of two 
solutions. 
Other methods less frequently used were liquid diffusion or vapour diffusion these being 
modifications of mixed solvent systems where the second solvent (usually precipitant) is 
introduced by slow diffusion processes. 
2.2.2 Salt Formation in The Solid State. 
Equimolar amounts (e.g. lOOmg BC and 108.7mg CSA) were ''veighed and mixed. The mixture 
was manually ground in a mortar for ca 4 min. The 1: 1 mixture was then carefully transferred to a 
14mm id. X 35 mm stainless steel cylinder with either one 8.34g, 12mm or two lg, 5mm iron balls. 
The cylinders were sealed and mounted on a Grindex Ball Grinder. The sample was ground 
mechanically for several minutes (typically 15 min) during which time the cylinder's temperature 
was observed to increase to approximately 45°C. The powder was then removed and analysed for 
any indication of phase change by measurement of the melting point and recording the solid's X-
ray powder pattern. 
2.3 Analytical Methods 
2.3.1 NMR. 
Crystals and powders were dissolved in deuterated chloroform, water or methanol and their 1H 
NMR spectra recorded at either 200 MHz (Varian VXR200) or 400 MHz (Varian Unity 400) with 
tetramethylsilane as reference. 
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2.3.2 Microanalvsis 
C, H, and N analyses were performed on a Heraeus Universal combustion analyser Model CHN-
RAPID. 
2.3.3 Thermal Analvsis. 
Resolving agent-substrate association was analysed by means of Differential Scanning Calorimetry 
(DSC). A Perkin Elmer PC7 Series thermal analysis system was employed. Indium (Aff = 28.5 Jig, 
m.p. = 156.7°C) and Zinc (Aff = 102.1 Jig, m.p. = 419.6°C) were used for calibrating the 
instrument. Sample masses ranging between 3 - 8 mg were placed in vented aluminium pans and 
heated at a constant rate of 10°C.min·1. The sample chamber was purged with N2 gas at a rate of 
30 ml/min. Melting points were detem1ined using a Linkam TH600 hot stage with a Linkam 
C0600 temperature controller. l11is apparatus was fitted with a Nikon SMZ-10 microscope for 
viewing melting and desolvation processes. 
2.3 .4 Polarimetrv 
A Perkin Elmer 141 Polarimeter was employed to measure absolute rotations of solutions to 
±0.001°. The instrument was set to zero using the appropriate solvent. Samples were pipetted into 
a 1 ml tube (l = 1 dm) and measured at A.= 589, 546, 436, and 365 nm. [ah. values reported were 
calculated by [ah. = 1 OOa/c where c = g of solute/I 00 ml solution. 
2.3.5 HPLC 
Chromatograms were obtained using a RESOL VOSIL BSA-7 (Bovine Serum Albumin) analytical 
column with a RESOLVOSIL guard column and a Waters Model 510 dual pump system. A 
Waters Model 440 absorbance detector set at A. = 254 nm. was used for detection. The mobile 
phase used was 50mMNa2HPOJNaH2P04 buffer at a flow rate of 0.9 - 1.0 ml/min giving a 1000 
- 1100 psi. column pressure. Samples for analysis were dissolved in small aliquots of the mobile 
phase or in mobile phase/EtOH 3: l v/v. This BSA column resolves BC-Lac. (a= I.9) 10. 
2.3.6 XRD 
X-ray powder patterns of the powdered resolving agents, substrates and co-ground products were 
measured on a PHILIPS PW 1050/80 goniometer with Ni-filtered CuKa radiation (A.= l.5418A). 
Step scans of 0.1° 28 over the range 6° s; 28 s; 40°, 2s per step, \Vere performed using automatic 
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divergence and receiving slits. Samples were mounted in a 20 x 14 x I mm aluminium holder. 
These powdered samples were carefully packed in order to minimise preferred orientation effects. 
Co-grinding conditions ensured particle sizes to be no greater than l 00 µm. 
2.3.6 X-Rav Crvstallographv. 
I~ Preliminary photography. Oscillation and Weissenberg photographs were taken using a non-
integrating Stoe goniometer. The crystals were irradiated with Ni-filtered CuKa radiation (A.= 
l.5418A) generated by Philips PWI 120 and PWI 140 X-Ray generators. Approximate cell 
parameters and space group data were calculated from the photographs. 
2) Intensity Data Collections. Intensity data were measured on an Enraf-Nonius CAD4 
diffractometer at 294K using graphite-monochromated Mo Ka radiation (A= 0.71069A). Accurate 
cell dimensions were obtained by least-squares refinement of 24 accurately measured reflections. 
Data in the range 1° s 0 s 25° were collected in the ro-29 mode with a maximum recording time of 
40s per reflection. Intensity control was performed every hour by means of 3 reference reflections 
and orientation control every 200 reflections. Measured intensities were corrected by Lorentz-
polarisation factors as well as an empirical absorption correction. 11 
3) Computation: 'The structures were solved by direct methods using the program SHELX-8612 
and refined by using SHELX-93 13 . The latter refinement involved the minimisation of 
I:(w(F0 
2 
- kF/)) where F0 and Fe are the observed and calculated structure factors respectively. 
Agreement between these latter two values were calculated by means of an RI factor = 
I:(IFol - IFcl)/ I:(IFoi) and wR2 = [I:(w(Fo 2 -kF/ )21 I:(w(Fo2) 2)f' where w = [cr2(Fo2) + (aP) 2 + bP]"1 
and P = [Max(O,Fr/) + 2F/]/3 . The values of a and b were chosen such that I:w(t,Ji)2 showed no 
marked systematic trends with the magnitude of sine and (F0 I (F0 )max)Y'. The program uses neutral 
atom scattering factors, f and f' and absorption coefficients from International Tables for 
Crystallography14. Further details on refinement methods follmv in section 4.2.5 where the 
individual crystal structures are discussed. From the refined atomic coordinates, thennal 
parameters, cell and space group data, X-ray powder diffraction patterns were computed using 
LAZY PULVERIX 15 . The latter powder patterns were used for comparison of the structure and 
polymorphic nature of crystals collected from large scale crystallisations with the structure 
determined by single crystal analysis. 
2.4 References 
1. See for example, Blade-Font, Tetrahedron Lett.,21, (1980), 2443, and R. Pellegata, M. 
Pinza, G. Pifferi, Synthesis, (1978)
1
614. 
2. L. Borka, Acta Pharm. Suec .. 16, (1979), 345. 
3. C. Marschalk, Bull. Soc. Chim., 43, (1928), 1388. 
4. J. Jacques, C. Fouquey, Organic Synthesis, 67, (1989), 1. 
5. E.P. Kyba, G.W. Gokel, F. de Jong, K. Koga, L.R. Sousa, M.G. Sielgel, L. Kaplan, G. 
Dotsevi, Y. Sogah, D.J. Cram, J Org. Chem., 42(26), (1977), 4173. 
6. S. Miyano, M. Tobita, H. Hashimoto, Bull. Chem. Soc. Jpn. 54, (1981), 3522. 
7. Y. Tamai, P. Heung-Cho, K. Iizuka, A. Okamura, S. Miyano, Synthesis, March 1990, 
222. 
8. S.fl. Wilen in Tables of Resolving Agents and Optical Resolutions, E.L. Eliel, Ed., 
University of Notre Dame Press, Notre Dame, Indiana, 1972. 
9. M.J. Brienne, C. Ouannes, J. Jacques, Bull. Soc. Chim. Fr., (1967) 613. 
10. S. Allenmark, S. Andersson, Chirality, 1:154, (1989), 160. 
11. A.C.T North, D.C.Philips, F.S. Matthews, Acta Cryst., A 24, (1968), 351. 
12. G. M Sheldrick, SHELX 76. Program for crystal structure determination, University of 
Cambridge, England, 197 6. 
13. G. M Sheldrick, J Appl. Crystallogr. In preparation. 
14. International Tables for Crystallography, Volume C (1992), Ed. A.J.C. Wilson, Kluwer 
Academic Publishers, Doordrecht. 
15. K. Yvon, W. Jeitschko, E. Parthe, J Appl. Crystallogr., 1977, 10, 73. 
25 
26 
3. RESULTS AND DISCUSSION 
3.1 Experiments in solution 
Within slight variations, the results from cocrystallisation experiments were categorised into three 
main groups: 
a) A non-crystalline cocrystallisation product, mostly an oil or thick paste. 
b) A crystalline product but resolving agent and substrate in separate crystals. 
c) Positively identified complexes (co-crystals). 
Thermal analyses of many of the crystalline products indicated undefined melting points or 
complex thermograms and ambiguous DSC traces implying a mixture of products. Varying 
degrees of salvation often hampered repr~ducibility. Added to this was the well known problem 
that the presence of even a very small impurity can hinder fonnation and growth of the first nuclei. 
Solutions left for crystallisation would therefore concentrate to such a degree of supersaturation 
that eventual precipitation yielded powders composed of too many components to be able to make 
sensible conclusions from the analyses. 
We concern ourselves exclusively with those results that indicated some form of association 
between resolving agent and substrate. Where this was achieved, ensuing experiments establishing 
the nature of association and possible selectivity are subsequently outlined for selected 
experiments. 
Table 3.1 : Complexes fom1ed from solution 
Components" So/\;ent MP.(°C) Stoichiometrl 
BC(210°C) + T A(l 70°C) Water 140 1:1 
BC-Lac (118°C) +TA° MeOH!foluene 100 2: 1 
126 2: l 
BC-Lac + CSA (200°C) Toluene/Hexane 55 I: l 
BC-Lac+ DBT (l50°C) Toluene/Hexane 94 1:1 
BC-Lac+ DMT (60°C) benzene/heptane · 86 1:1 
GAM(l 73°C) + MBA(liql MeOH 187 l:l 
GAM + CIND(201°C) EtOH/EtOAc 91 1:l 
a) Melting points of the pure components follow in parentheses 
b) These were established by a combination of CHN and NMR analyses. 
c) See sect 3.4, and d) chapter 4 for further details. 
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BC: In the light of the various unprotected amino acids resolved with strong resolving 
acids (as mentioned in Sect. 1.4 ), the failure of any of the acids BNP, MA and CSA to resolve, 
partially resolve or even forin a salt with BC was somewhat surprising. A serious problem in 
cocrystallising BC with organic resolving acids is the drug's poor solubility in almost all organic 
solvents (4.3mg/ml in water (pH 7.6) and less than 0.05 mg/ml for all organic solvents (MeOH, 
EtOH, CHCh etc.)). An additional problem is that BC cyclodehydrates readi!y at low pH to form 
BC-Lac1• Co-crystallising (R)-(-)-BNP acid with BC in fact resulted in lactam formation (proven 
by NMR and m.p.). The co-crystals identified with TA grew after 3 months and were difficult to 
reproduce. No evidence could be found in the literature of any organic compound, bearing a chiral 
GABA moiety, resolved as the free amino acid by cocrystallisation with an acidic resolving agent. 
Both racemates of 2-methyl-GABA~ and 4 methyl-GABA (4-Aminopentanoic acid)3, for example, 
are separated as their N-phthalimido and N-Carbobenzyloxy derivatives respectively. These 
derivatives are co-crystallised with quinine. 
BC-Lac: Co-crystallising BC-Lac with acids in polar solvents led to oily precipitates. Non-
polar solvents gave some complexes as indicated in Table 3 .1. Given the ionic nature of the salts 
used in resolutions, one can predict that the best solvents will be polar ones. Solvents such as 
hexane or benzene sometimes even prevent the fom1ation of salts. Thus the price paid for these 
more crystalline complexes was their poor selectivity. With the exception of the BC-Lac.TA 
complex, chiral HPLC (BSA column) analyses of all other BC-Lac complexes indicated 
approximately equal quantities ofR and S isomers. , 
GAM: The GAM.CIND co-crystals were finely powdered precipitates. NMR, DSC, 
XRD and microanalysis confim1ed phase transfom1ation after co-crystallisation and l: 1 acid: base 
stoichiometry. In the absence of information detailing chiroptical properties of(+)- and (-)-GAM, 
as well as any existing chromatographic separation methodology for ee analysis, establishing 
enantioselectivity was difficult. This was made easier in the GAM.MBA complex, where suitable 
single crystals could be grown for X-ray analysis to establish absolute configuration (see chapter . 
4). This was a most interesting result as little evidence concerning separation methodology for 
analogous glutaric acid monoamides can be traced in the literature. Morlacchi et al. in 1975, 
concerning themseives with the absolute configuration of 2-Phenylpyrrolidine, resolved 4-phenyl-4-
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carboxamidobutyric acid (19) through salt formation with D(-)-threo-(p-nitrophenyl)-2-amino:..l,3-
propanediol (20) in ethanol.4 
19 20 
This Chloramphenicol base (20) was not available to us. to check its effectiveness with GAM. 
Various dicarboxylic acids are resolved by this base5•6 . 
3.2 Solid State experiments 
Analyses of the co-ground products were similarly categorised to the solution products. Instead of 
oil formation, we sometimes obtained poorly crystalline material, \vhich was almost amorphous. 
This type of "damage" inflicted on a crystalline powder was detected in the recorded X-ray powder 
pattern of the product. These products \Vere devoid of any distinct peaks in the intensity vs. 
reflection angle plots as sho"rn in Figure 3 .1. 
5 10 15 20 25 30 35 40 
2 Theta (deg.) 
Figure 3.1: XRD powder pattern indicating amorphous structure. This example is 
the product of co-ground HMD3 + BC powders. 
Table 3.2 : New phases identified in solid state 
co-grinding experiments. 
Components MP. (C) 
BC-Lac(210°C) + TA(l70°C) 100 
BC-Lac + CSA(200°) 70 
BC-Lac+ L-MA(l32°C) 45 
Had complex fom1ation between a resolving acid and BC succeeded in the solid state, this may 
have been a suitable bypass to the lactam formation problem. Solid state co-grinding attempts with 
BC failed. BC-Lac formed some interesting complexes as shov.rn in Table 3.2. The BC-Lac.L-MA 
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complex (indicated by XRD, microanalysis and melting point) was too unstable to continue 
experimentation. Interestingly the BC-Lac.CSA complex exhibited different morphology from the 




5 10 15 20 25 30 35 40 
2 Theta 
Figure 3.2 : XRD powder patterns of: a) CSA, b) BC-Lac, c) BC-Lac.CSA co-ground 
powders, and d) BC-Lac.CSA co-crystals grown from Toluene/Hexane solution 
Subhmation Experiment: The BC-Lac.TA complex was obtained only after co-melting 2.0g 
BC-Lac with l .53g TA. Subsequent separation was attempted by fractional sublimation after it 
was established that BC-Lac sublimes at 80°C u~der vacuum whereas TA remains a solid at this 
temperature. This was inspired by the recent reports of Acs et al. The Authors developed new 
methods of optical activation of racemic bases (liquids) based on the selective distribution of the 
enantiomers between a chiral solid and achiral vapour phases. The chiral solid phase was formed 
by tartaric acid (and its derivatives) and racemic bases. Upon heating in vacuo these solids released 
a portion of the bases. Both the distillate and the residue contained an optically enriched base 
mixture with each containing opposite configurations in excess 7. 
The TA.BC-Lac complex melt was cooled and reground to a fine powder. The XRD powder 
pattern indicated a phase change relative to the sununated phases of the two components. The 
powder was heated to 80°C under vacuum in a HOCHI T0~51 heating gun (see Figure 3.3) and 
maintained at this temperature for 12 hours. 0.3g sublimate was collected on a cooler section of the 
gun; [a]o = +5.3° (Lit8.= +39° for S-(+)-BC-Lac) giving only a 14% ee. 
Figure 3.3 : Schematic diagram showing sublimation experiment with TA.BC-Lac 
complex using a BUCHI T0-51 heating gun 
30 
In the interest of attaining the objective of this project the solid state reactions were not pursued. 
Purely from a _point of view of effecting enantioselective recognition it \vas clear that fractional 
crystallisation was the method of choice, since by now resolution trials involving BC-Lac and 
GAM were proving to be successful. From a mechanistic point of view, however, these solid state 
experimental results are starting points for further investigations concerning molecular mobilities in 
solid state phase transfonnations: 
3.3 Host-Guest .Chemistry 
Attempting_to co-crystallise the host compounds HMD3, HMD5, or HMD6 with one of BC, BC-
Lac or GAM was not successful. Suspending the host in hexane and allowing for selective 
inclusion by dissolving the "guest" (drug m9lecule) in the nori-polar solvent was not possible due to 
the drugs being polar compounds. In the more polar solvents such as CH3CN, host and guest 
crystallised out separately. This was detected mainly by the DSC traces of the precipitates showing 
no nev.1 melting points relative to the those of the individual components. The reason for this was 
not evident in the case of BC-Lac. The host compounds include mainly alcohols, ethers, ketones 
and esters (as mentioned in chapter 1), and seemingly not the more polar acids such as GAM. 
Added to this is the previously mentioned sensitivity of a host compound to the size and shape of 
the molecule it will include. It may simply be a problem of these drug analogues being too large for 
inclusion. 
3.4 BC-Lac with TA9 
Crystals of a 2: 1 BC-Lac:TA complex were grown from a 4: 1 molar ratio BC-Lac:T A solution in 
toluene and dry methanol. The toluene:methanol (85: 15) ratio was critical for recovering the 
desired enantioselective complex with m.p. 126°C. Solutions allowed to crystallise rapidly readily 
12 
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yielded a different complex of lower melt I00°C. The NMR spectra shown in Figure 3.4 confirm 
the species present in the high melt complex. Integration of the protons cSH 2.43(1H, dd, J 8.6, 
17.0Hz, CHCO, BC-Lac) and 4.54(2H, s, CHOH, TA) confirmed 2:1 BC-Lac:TA ratio . 
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On analysis of the crystal structure of the high melt complex, two (R)-(-)-BC-Lac molecules were 
found to complex to one (2R,3R)-(+)-TA molecule. Unfortunately no single crystals of the low melt 
complex were suitable for similar analysis. It \Vas therefore not known whether this complex 
consisted of two (S)-(+)- or one (S)-(+)- and one (R)-(-)-BC-Lac molecule co-crystallising with 
TA. Crystal data of the high melt complex are given in Table 3.3. 
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The absence of proton transfer distinguished these co-crystals from the diastereomeric salts 
nom1ally formed bet\veen acids and bases. The lactam is too weak a base to be protonated in the 
presence of TA. It appears that similar problems \vere encountered in the resolution of 2-
Phenylpyrrolidine with TA 4; as the resulting salt was recrystallised 9 times from EtOH until 
constant rotation was reached. Salt fonnation was evident though, as the amine was subsequently 
liberated by addition ofNaOH. 
In our complex, the selectivity of crystallisation appears to result from the chiral environment 
created by the TA molecules enveloping the BC-Lac molecules. An interesting hydrogen bonding 
interaction network was found in this complex. TA is a dicarboxylic acid. Each. end of the acid 
finds itself facing the amido moiety of a lactam molecule and hydrogen bonding to it by means of a 
typical 8-membered ring R2
2(8) (graph set notation 10) interaction. The TA and two distinct (R)-BC-
Lac molecules forrn a "strand" as indicated in Figure 3.5 
Figure 3.5 : The asymmetric unit in the TA.BC-Lac complex 
Figure 3.6: Packing diagram of TA.BC-Lac complex as projected down [100]. Nitrogen 
and chlorine atoms are represented by solid and dotted circles respectively 
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These strands are interlinked by secondary hydrogen bonds as shown in Figure 3.6. Together these 
interactions fom1 a chain of rings nmning parallel to the polar b axis in helical fashion as depicted 
in the schematic diagram in Figure 3.7. Two such distinct chains with a C2
1(7) "backbone" are 
interspersed throughout the structure 
C~(7) 
Purity: 
Figure 3. 7 : Schematic representation of 
hydrogen bonding in the TA.BC-Lac complex. 
Two distinct hydrogen bonding columns are 
found parallel to the unique axis: 
· Column 1: Column 2 
a o ... o 2.619(4)A 2.559(4)A 
b N ... O 2.886(4)A 2.992(4)A 
c o ... o 2.972(4)A 2.935(5)A 
The bonds labelled a,b and c are indicated in the 
diagram. 
Enantiomeric purity was detennined by usmg the same chiral BSA colunm as mentioned 
previously. The BC-Lac was separated from the complex by dissolving the latter in n-butanol and 
washing with a 1 M aqueous sodium bicarbonate solution. The n-butanol ';vas then removed under 
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vacuum affording the pure BC-Lac. Elution times were ca 2 and 9 min for the S and R 
enantiomers respectively. Contamination with the S enantiomer was still detected, even after 3 
recrystallisations. Optimisation of this procedure was not pursued as the resolution of BC via its 
synthetic precursor GAM was proving to be more successful. 
3.5 References 
1. S. Ahuja, Analytical Profiles of Drug Substances, vol. 14, K. Florey, Ed. (Academic 
Press, New York (1985)), 538. 
2. R. Adams, J Am. Chem. Soc., 81, (1959), 4946. 
3. D.R. Pilpauskas, K.D. Kopple, Tetrahedron, 32, (1976), 2245. 
4. F. Morlacchi, V. Losacco, V. Tortorella, Gazz. Chim. Ital., 105, (1975), 349. 
5. Y. Kawanami, Y. Ito, T. Kitagawa, Y. Taniguchi, T. Katsuki, M. Yamaguchi, 
Tetrahedron Lett., 25, 857. 
6. H.W. Krause, C. Meinicke, J Prakt. Chem., 327, (1985), 1023. 
7. M. Acs, T. Szili, E. Fogassy, Tetrahedron Lett., 32, (1991), 7325 . 
. 8. A. Shoenfelder, A. Mann, S. Le Coz, Synlett, 1, (1993), 63. 
9. This section of the thesis has been accepted for publication: "Resolution of optical isomers 
of 4-amino-p-chlorobutyric acid lactam by co-crystallisation", M.R. Caira, L.R. 
Nassimbeni, J.L. Scott, A.F. Wildervanck, J Chem. Crystallogr., in press (ref. no. 
JCCA418). 
10. J. Bernstein, R.E. Davis, L. Shimoni, N. Chang, Angew. Chem. Int. Ed. Engl., 34, (1995), 
1555. 
4. RESOLUTION OF GAM WITH MBA 
4.1 Experimental Procedures 
4.1.1 Resolution ofGAM 
The following scheme shows the procedures for optical resolution of GAM. 
+ H N-S' 2 
0.3 M in Ac/MeOH 
ca. 24 hrs 
R-co2-. H3 +N-S' 
(N Salt) ii) 0.3 M HCI 
R = Cl-0-C. 
- CH2CONH2 
where 








R-C02H + er H3 +N-S' 
(precipitate) 
~I S'= v 
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GAM (18g, 74.4nunol) was dissolved in methanol (250ml) and warmed to ca 60°C. (S)-(-)-MBA 
(9.48ml, 74.4mmol) was carefully added via a graduated pipette, and the warm solution stirred for a 
few minutes. The resulting 1: 1 GAM.MBA solution was cooled to room temperature and left 
standing in a dark place· for ca 24 hours affording colourless plate-like crystals (9.86g, 73% yield as 
calculated for one enantiomer). The crystals were isolated by filtration, dried and dissolved in water 
(200ml) by heating to ca 90°C. 3M •• HCI (90.5ml) was added at this temperature after which the 
solution was allowed to cool to room temperature (or even refrigerated). The precipitate was filtered 
at the pump, washed with water and vacuum dried to give (RH+)-GAM (6.23g, 95% yield, 69% 
overall yield). The mother liquor of the crystallisation was isolated and concentrated further by 
evaporation. The resulting precipitate was removed from the solution by filtration yielding 12.6g p 
• When exposed to light for several hours these solutions appeared to darken. 
•• The acid concentration can vary. It is important to add l molar equivalent. 
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salt (still contaminated with n salt by a percentage dictated by the eutectic). The p salt was then 
purified by subsequent recrystallisations from an ethanol I ethyl acetate solution. 
4.1.2 Conversion of (R)-GAM to (R)-baclofen 
Cl 
To a solution of sodium hydroxide (2.8g, 69.4nm10l) in water (50ml) was added (R)-GAM (6.57g, 
27.2lmmol) at ca. 20°C. A 10.8% aqueous solution of sodium hypochlorite (28.3g) was then added 
over 2.5h at 0°C via a dropping fum1el. The solution was stirred for a further 12h at room 
temperature (ca. 20°C) after which time it was carefully neutralised (pH 7.5) with dilute hydrochloric 
acid. The precipitate was filtered off at the pump, \Vashed with water and acetone. The precipitate 
was then boiled in methanol to remove the last traces of GAM and filtered to yield pure (R)-baclofen 
(1.3g, 22% yield). The mother liquors were reduced in volume in vacuo to yield more product which 
was boiled in methanol and filtered to give another 2.05g of (R)-baclof~n (3.35g total, 57.6% yield). 
A portion of (R)-baclofen was then converted to its hydrochloride salt. by treatment with cone. HCl. 
4.2 Analyses 
4.2.1 NMR 
The GAM : MBA ratio was initially established by NMR spectroscopy. The sample was run in 
CD30D (Figure 4.1 (a)). The integration of the two protons bonded to the chiral carbons viz. OH 
evidence of a I: 1 ratio. The final product, (R)-(+)-GAM, was also characterised by NMR. The 
spectrum was identical to that of racemic GAM (starting material), proving the product-to be the free 
acid. (Figure 4.1 (b)). 
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Figure 4.1: NMR spectra ofa) n salt b) (R)-(+)-GAM 
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4.2.2 TI1ennal analvsis 
Differential Scanning Calorimetry (DSC) showed the same melting point for both diastereomeric 
salts (187°C) by a characteristic broad endotherm (Figure 4.2). The DSC data of 16 conglomerate 
· diastereomeric salt pairs recently analysed by Kozma et al. indicated that an efficient resolution can 
be expected if there is at least a 20°C difference between the melting points of these salts1. With a 
melting range of ca 25°C it was difficult to distinguish between the p and n salts by thermal analysis. 
Figure 4.2 also shows a DSC trace of (-)-GAM.MBA (p salt) mixed with (+)-GAM.MBA (n salt). 
The approximate ratio of the two salts are 87: 13 p:n (corresponding to the subsequently established 
eutectic composition). Either salt, when contaminated with the opposite diastereomer, exhibited a 
lowering of the melting point. Attempts at establishing a melting point phase diagram failed due to 
the aforementioned broad endotherm problem. Both racemic and enantiopure GAM melt at l 73°C, 
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Figure 4.2 : DSC trace of then salt (solid line) and of the p salt (87%) 




%C 0/oH 0/oN 
Celle. for salt·: 62.89 6.34 7.72 
Found 62.37 6.40 7.65 
Cale. for (R)-(+)-GAM 54.67 4.96 5.79 
Found 54.62 4.98 5.72 
Cale. for (R)-(-)-Baclofen: 56.21 ' 5.66 6.56 
Found 56.30 5.78 6.52 
4.2.4 Polarimetrv 
Optical rotation measurements yielded the results shovm in Table 4.1. · 





















These values remained constant after further recrystallisations. The error for these lm"' rotational 
·values was 0.5°. 
4.2.5 Crvstal structures 
Suitable single crystals of the salts were grown by slow evaporation from a methanol solution as 
described previously. Crystal morphology of the two salts differed markedly (see Figure 4.3). The 
thin plate-like crystals of the more stable salt contrasted with the long rod-like "fibres". of the more 
soluble salt. A suitable crystal of each salt was selected, cut to size, and mounted on a glass fibre for 
Oscillation and Weissenberg photography for preliminary determination of cell parameters and space 
group data. Single crystals of the p salt proved to be unstable when removed from the mother liquor 
and were therefore mounted in a 0.3 nm1. id. Lindemann capillary tube. The !ability and poor 
crystallinity of the p salt made data collection extremely difficult. Two sets of reflection data were 
. collected from two different crystals and in both attempts less than half the total number of 




Figure 4.3 : (a) Plate-like crystal of then salt, (b) long needles of the p salt in mother liquor. 
N Salt: The first oscillation photograph of a single crystal of this compound showed no synunetry. 
Reflections in the zero-level Weissenberg photograph were observed to be mirrored around the 
mutually perpendicular axes . Together, these photgraphs indicated 2/m Laue symmetry. ~ was 
measured from a second zero-level Weissenberg photograph \Vith the crystal remounted along the 
unique axis . Upper level Weissenberg photography showed no absences amongst the general 
reflections indicating a primitive lattice. No systematic absences amongst the h O I reflections proved 
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the absence of any glide planes. Thus the only conditions for systematic absences were: 0 k 0, 
k = 2n + 1, confirming the polar space group P2 1• 
The structure was s?lved and refined as previously described (Sect. 2.3.6). In contrast to SHELX-76, 
the updated refinement program SHELX-93 recognises polar space groups and applies the 
appropriate polar axis restraints2• Anisotropic thermal parameters were assigned to all non-hydrogen 
atoms. All H atoms were located in difference electron density syntheses and· were placed in 
geometrically generated positions (C-H ::;; IA)and refined with positional paran1eters riding on the 
parent atom. Variable isotropic thermal parameters were assigned for chemically equivalent groups. 
The. -NH3 + hydrogen atoms were allowed to refine without restraints. 
P Salt: Preliminary space group determination proceeded similarly to the above method described for 
the n salt. This time the unique axis coincided with the elongated axis of the crystal shown. in Figure 
4.3. The oscillation photograph showed a mirror plane and subsequent establishment of the crystal 
system and space group was similar to that of the n salt. Spurious reflections indicating twinned 
crystals were often observed on photographs. Structure solution proved to be non-trivial. Both 
refinements using the two different sets of collected data showed disorder in the resolving agent's 
phenyl ring. All reflections with I < 2cr(I) were omitted. No hydrogen atoms could be located, and 
placing these in geometrically idealised positions increased the R value markedly. Phenyl rings were 
refined as idealised hexagons with common variable isotropic t~ennal parameters. Refinement with 
the carbon atoms of ring A included, gave rise to peaks in the electron density surrounding the phenyl 
ring suggesting an alternative orientation (ring B) inclined at 72° to the plane of ring A. This was 
modelled by allowing two possible orientations of the phenyl ring whose site occupancy.factors were 
refined to 0.52 and 0.48 for ring A and B respectively. 
N(25) 
Figure 4.4 : Molecular diagram of (S)-(-)-MBA in the p salt showing disorder in the phenyl ring. 
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Results. Details of the crystal data and structure refinement of the two salts appear in Table 4.2. 
Fractional atomic co-ordinates, bond lengths, bond angles, selected torsion angles and structure 
factor data appear in Tables A. I to A.8 in the Appendix. 



















Data I restraints I parameters 
Final R indices [1>2cr(I)] 
R indices (all data) 
Flack parameter x 
Largest diff. peak and hole 
(R)-GAM. (S)-MBA (n salt) 







b = 20.67I(3) A · 
c = 8.354(1) A 
f3 = 107.39(2)0 
943.9(4) A3 
2 
I .277 g.cm·3 
1.269 g.cm·3 
0.222 nmf 1 
384 
0.4 x 0.5 x 0.3 n1111 
1.97° to 24.97° 
-6 $ h $ 6 
-24 $ k $ 0 
0 $ l $ 9 
I837 
1703 [R(int) = 0.0301] 
I703 I 6 I 253 
RI = 0.0296, wR2 = 0.0938 
RI= 0.0387, wR2 = 0.1075 
-0.12(9) 
0.202 and -0 .. 236 e.A-3 
(S)-GAM. (S)-MBA (p salt) 







b = 5.474(1) A 
c = I4.434(2)A 







0.3 x 0.3 x 0.3 nun 
1.55° to 24.99° 
-15Sh$ 15 
o sks 6 
0 $} $ 17 
2110 
2026 [R(int) = 0.0383] 
2026 I 0 I 138 
RI = 0.1258, wR2 = 0.3I ll 
RI = 0.2244, wR2 = 0.3134 
0.0(5) 
0.499 and -0.345 e.A-3 
* The density of the p salt was difficult to measure due to the cracking of these crystals once removed 
from the mother liquor. 
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N1 
Figure 4.5 Crystal structure diagram of GAM.MBA (n salt) showing numbering scheme. 
Absolute configuration: 
Knowing the absolute configuration of (S)-(-)-MBA, R and S configurations were assigned to dextro-
and levorotatory GAM in th~ n and p salts respectively. Compari~on of the Flack absolute structure 
parameter with its estimated standard deviation (esd), also confirmed the correct assignment as its 
value was close to zero3. Assignment of absolute configuration in the p salt was more difficult due to 
the high themlal motions of both the amide and carboxylate moieties (see Table A.4). By means of 
electron density mapping, (R)- and (S)-GAM, in ionic forn1, can only be differentiated from one 
another by the difference in the X-ray scattering powers of an oxygen and nitrogen atom. Assignment 
was therefore made by means of hydrogen bonding characteristics and supplementary polarimetry 
experiments. For the GAM isolated from the latter discussed salt, a.0 = -9.5° (MeOH). This 
confirmed the two crystalline compounds to be diastereomers (see Table 4.1). 
Conformation 
As evident from Figure 4.6 the conforn1ations of GAM's enantiomers in the two diastereomeric salts 
are essentially similar. Ionisation in then salt was confim1ed by the equidistant C-0 bond lengths in 
the carboxylate moieties and three hydrogens were located in tetrahedral geometry around the 
nitrogen atom N(25). Proton transfer in the p salt could not be readily justified since the C(l)-0(13) 
C(l)-0(14) bond lengths, l.30(2) and l.22(3)A respectively, differed significantly. Due to high 
e.s.d's no conclusion could be dra,vn. Table 4.3 shows Newman projections of some of the torsion 





(R)-(+)-GAM (inn salt) 




(S)-(-)-GAM (in p salt) 
Figure 4.6 : Conformation of the enantiomers of GAM . Both are viewed down a line 
perpendicular to the C(3)-C(6) bond. lying in the plane bisecting L C(2)-C(3)-C(4). 
"' 
Table 4.3 : Newman projections showing representative torsion angles 
in the diastereomeric salts. (see Fig. 4.5 for atom numbering scheme) 
Ph Ph 013 "' 
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cs~ ~!¥' ~N25 ~cs~ C1l e c2 ca· 3~ 2 C1 2 cs 19 C2 c 4C4 
cs 014 N16 




~·C'~·C$ ~:· 9~ . 1s C19 C4 C2 C17 
C2 C4 
cs 013 N16 
tide' 
-3.8(5) -49.6(3) 17-Ll(2) -65.8(3) -29.8(4) -42.1(4) 
-13(1) 62( 1) -179(2) 34(2) 40(4) A -20(4) B -82(3) 
Relative tf) the C(3)-C(6) ... C(9)-Cl(12) axis, bonds C(4)-C(5) and C(l)-C(2) are parallel and oblique 
respectively, with C(3)*-H bond syn-periplanar to the phenyl ring. This characteristic conformation 
was similarly found in the crystal structure of the (R)-(-)-BC.hydrochloride salt4. Comparing the 
resolving agent's conformation in the two salts is complicated by the disorder found in the amine's 
aromatic ring carbons. The C(l 8)-C(l 9)B bond length (I. 72A) and N(25)-C( I 8)-C(l 9)B bond angle 
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(96.7°) (Fig. 4.4) niake no real chemical sense, and are clearly an artifact of the poor intensit)1 data. 
Added to this is the fact that the plane of ring Bis almost parallel to the polar 5. 72A b axis (Lq>B,b 
· axis = 5.5°) resulting in 3A carbon ... carbon contacts. This phenyl ring· \\'as therefore omitted in 
subsequent packing diagrams to avoid unnecessary confusion. The characteristic torsion angle 
N(25)-C(l8)-C(l9)-C(20) shown in Table 4.3 shows a disfavoured syn-periplanar N(25) ... q>A 
interaction in this p salt as opposed to the synclinal N(25) ... <p interaction in then salt. 
Hydrogen Bonding: 
Brianso et al. have reported several salt structures involving MBA as resolving agent and have found 







Studying the two salt structures of MBA with GAM, two quite distinct pattems are observed. Table 
4.4 lists the hydrogen bonds found in the two crystal structures and Figure 4.7 shows packing 
diagrams illustrating these. 
Table 4.4 : Hydrogen Bonds 
D-H .... A/A D-H/A D .... A/A H .... A/A D-H .... A/deg 
N Salt 
a N(25)-H(253 ) ... 0(13) 0.94(3) 2.720(3) 1. 79(3) 173(4) 
b N(25)-H(25 l) ... 0(14 f 0.96(4) 2.763(3) 1.81(3) 17'.3(3) 
c N(25)-H(252) ... 0(l5fi 0.95(3) 2.806(4) 1.86(3) 175(3) 
d N( 16)-H( 161) ... 0( 14 )'ii 0.84(5) 2.962(4) 2.16(5) 159(4) 
P Salt 
a N(25) ... 0(13) 2.71(2) 
b N(25) ... 0(13)iv 2.80(1) 
c N(25) ... 0(14r 2.82(2) 
d N(l6} ... 0(15)vi 2.93(2) 
N(l6) ... 0(15)v 3.26(6) 
(i) x-1, y, z (ii) x-1. y, z-1 (iii) x+l. y. z+l 
(iv) 1-x, y-'l-2. 1-z (v) x, y-1. z (vi) -x, y-1/2. -z 
In both structures the anunonium cation forms three hydrogen bonds to various oxygen atoms of 
GAM. No hydrogens were located in the p salt so that the ensuing discussion will be in· terms of 
donor.. .. acceptor interactions only (despite having located the hydrogens in the n salt) so that 
comparisons can be made. 
(A) (B) 
Fib'Ure 4. 7 : Packing diagrams of A) p salt viewed as prqjected down [ 100] and 
B) n salt as prqjected down [OlOJ. Niirogens are represented as filled circles and 




The p salt indeed shows such chains consisting of two chemically distinct hydrogen bonds a and c 
(see Figure 4.8) linking together the carboxylate anions of vertically (along b) stacked GAM 
molecules. The two screw-related chains are interlocked by a third hydrogen bond b, altogether 
composing a "chicken wire" structure: a two-dimensional network .of rings that have b in conunon. 
Complementing this we find the amide moieties of the GAM molecules facing one another from 
opposite sides of a 21 axis, once again fanning a helical chain of hydrogen bonds, d and e. 
R~(8) 
(A) (B) 
Figure 4.8 : Schematic representation of the hydrogen bonding found in the (A) p salt 
· · and (B) n salt. Some of the defining patterns are annotated by graph set notation 
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In contrast to the crystal's hydrogen bonding network running parallel to the 21 axis, the n salt (the 
more crystalline salt) crystallises in distinct layers, perpendicular to the 21 axis, alternately "glued" 
together by a web of hydrogen bonds forming a '·chain of rings". Here the amide and carboxylate 
moieties are neatly locked around an ammonium cation, the latter in tum interlinking the rings so 
formed by a fourth N-H. .. O hydrogen bond. One notes the ·similarities/differences in the two 
patterns by means of a graph set notation. On a secondary level notation (i.e. N2 (ac) and N2 (ab) for 
the p and n salts respectively) one can delineate C2
2(6) patterns for both. At higher level notations 
when incorporating the characteristic ring-like structures the graph set notations, Jli3( IO) and R33( I 0) 
for the p and n salts respectively, differ. To sununarise: the n salt has rmg structured . 
carboxylate ... ammonium ... amide interactions whereas the p salt has separate rmg structured 
carboxylate ... ammonium ... carboxylate and amide ... amide interactions. 
A) 
B) 
Figure 4. 9 : Stereo diagrams showing A) an inclined view down the unique axis of 
the p salt with the helical N .. O interaction pattern. B) The distinct layers found in 
the· n salt. Nitrogen atoms are represented by filled circles 
4.2.6 X-Rav powder Diffractometrv 
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Figures 4. lO(a) and (b) show calculated and observed XRD powder patterns of the two diastereomers 
from large scale (typically I Og salt) separations. The calculated patterns are·based on the data from 
the single crystal X-ray analyses. This was additional proof that the n salt was not contaminated 
(within a 5% detection limit) with its diastereomeric counterpart due to the intense peaks in the p 
salt's powder pattern not having counterparts in that of then salt. Figure 4. lO(c) indicates that (±) 
GAM crystallises as racemic crystals, since its crystal structure differs from those of its R and S 
enantiomers. It must be emphasised here that this R enantiomer was isolated from the p salt that 
remained in the mother liquor after removal of the n salt precipitate. The p salt was purified by using 
a different solvent system (ethanol and ethyl acetate, as described in 4" 1.1 ). 
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The crystal structure of (R)-Baclofen Hydrochloride (R-BC.HCl) has been published4 . Figure 4.1 O(d) 
shows the good agreement between the powder pattern computed from the published data and the 
.. powder pattern measured from our sample of R-BC.HCI. The intense peaks in the powder pattern of 
·. racemic BC.HCI do not have counterparts in the R-BC.HCI powder pattern. It may be necessary to 
point out that the "ideal" powder pattern as calculated by LAZY PUL VERIX relies on complete 
random distribution in particle orientation. This condition is not met when particles take on a 
preferred orientation due to their non spherical morphologies. Throughout the powdered sample, 
certain crystal planes will be less exposed to the X-ray radiation than others. Intensity discrepancies 
in Figures 4.10 (a) - (d) can generally be attributed to this effect. 
Figure 4.10: XRD Spectra of: 
(a) n salt 
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(b) I> salt 
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(d) (R)-(-)-BC.H)'<lrochloride 
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A sample of (R)-Baclofen as converted from our separated (R)-GAM was submitted to Fine 
Chemicals Coorporation for Chiral High Perfom1ance Liquid Chromatography analysis on a (D)-
Penicillamine column (2 mmol aq CuS04 mobile phase). The result indicated an enantiomeric excess 
of99.7%. 
4.3 Solubility Diagram. 
The possibility of scaling up this separation process for industrial purposes prompted the need to 
optimise the crystallisation conditions such that yield and purity were maximal. In the absence of 
either salt being solvated, dissolution - crystallisation equilibria were demarcated by concentration vs. 
diastereomeric salt composition plots as described in section 1.2.1.2 . Concentrations at 24°C of the 
saturated solutions of p and n salts were detem1ined by UV spectroscopy, using a Philips PU8700 
series UV/visible spectrophotometer. Standard solutions were made in the concentration range 0.25-
1.5 mg/(ml solution). The linear relationship A = l .050C (A = absorbance and C = concentration in 
mg/(ml solution)) was established by measuring absorbances at A.ma.~ = 260.6nm (correlation 
coefficient r = 0.9998). From the measured absorbances of solutions saturated at 24°C and diluted 
l: l 00 the solubilities (in Methanol) were calculated to be: 
p salt 136 ± 5 mg/(ml solvent) 
n salt 32 ± l mg/(ml solvent) 
A preliminary eutectic composition was established by mea~uring the optical rotation of a solution 
saturated with both salts. 
[a]o = -9.4 ± 0.5°, C = 152 ± 5 mg/(ml solvent) 
Using the optical rotation values listed in Table 4.1 and assuming salt composition directly 
proportional to rotatory powert this constituted a 84:16 p:n ratio. Four extrapolated points with salt 
ratios 0 < P < 84 : 100 > N > 16 and corresponding concentrations 32 < C < 152 mg/(ml solvent) 
were calculated. Four 5 ml methanol solutions were made up in accordance with the latter calculated 
· t This assumption is valid if the p and n salts (dissolved in MeOH) are completely unassociated with one 
another. This was confirmed within the large error of low optical rotational values (typically ±2° for 
_30 <[a.Jo< +30). 
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· values, adding to these a marginal excess of n salt to ensure saturation of this less soluble component 
after equilibration. Complete dissolution of the p salt was assumed in the specified composition vs. 
concentration range. 





















By measuring the densities of the above solutions, concentrations could be expressed in terms of 
%mass. (p = 3.43xl0-4C + 0.786 mg/ml., correlation coefficient r = 0.997). 
Me OH 
80% •• · .,. •• · ·1· ··· ·1·····1··· ., .... , .... ,. ··· r •• • ·r·· · · 
N salt o.s o.e1 p salt 
Figure 4. 11 : Solubility diagram showing phase equilibria for the n and p salts dissolved in methanol 
Intersection of the "best fit" line through the tabulated data points (as transferred to a triangular 
phase diagram) with the 152mg/ml (81.8% by mass) horizontal, gave a 87:13 p:n eutectic 
composition. In theory it would therefore be possible to obtain a 87% recovery of (R)-(+)-GAM from 
the racemic starting material. This is extremely high by many separation standards and is therefore 
suited to an industrial scale process. 
4.4 Possible structural evidence for the selectivity. 
The most intriguing studies are those that have probed the crystal structures of diastereomeric salts 
by X-ray crystallography, such as the studies conducted by Larsen et al. ~·9, and Yoshioka et ai. 10 
Various attempts to answer this daunting question have appeared in the literature from time to time. 
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Zingg et al. conducted a careful study of the relations between structure and energetics of association 
of stereoisomeric salts of mandelic acid with MBA, ephedrine, and pseudoephedrine in the crystalline 
state and in solution 11 . Physical properties such as heats of fusion, heats of solution, heats of 
protonation, dissociation constants, and equivalent conductances of the stereoisomeric salts were 
carefully measured, giving rise to some interesting correlations between these properties and observed 
selectivities. The concluding remarks of the authors, however, were that they '· .... were unable to 
provide a complete structural interpretation of the ion-pairing behaviour, even for this carefully 
chosen system" (Zingg et a/. 11 ). 
Crystalline phase interactions of small molecules. 
In terms of large molecular structures exhibiting chiral discrimination when reacted together with 
racemic mi,..1ures of small chiral molecules, the problem is simplified by rigidity of a "host" with a 
chiral "receptor" site in which only one enantiomer of the '·guest" will fit preferentially. The 
preferential formation of one diastereomeric salt between the large acid lasalocid and various MBA 
derivatives was successfully rationalised by this lock and key analogy 1 ~. Three oxygen atoms of this 
large cardiotonic agent hydrogen bond to the anunonium cation of MBA and the steric bulk 
surrounding the acid's "cavity" predetermines the preferred enantiomer of MBA, itself modified with 
steric "attachments" such as bromine. Similar arguments are used in discussing structural differences 
in the brucine and strychnine salts with N-benzoyl-D-alanine and N-benzoyl-L-alanine respectively. 
Brucine, for example, forms monolayered corrugated sheets creating almost rigid channels between 
the sheets, and '· .. the preference for complex.ation \\'ith the D or L isbmer must depend on the shape 
and size of the cavity" (Gold et al. 13). When we study small drug molecules interacting with small 
resolving agent molecules such as those in our present study, we find highly intricate interaction 
networks that are extremely sensitive to the physical conditions under which interaction occurs. The 
loss in "bulky rigidity" has increased the variables controlling chiral recognition to such an e"-1ent 
that it becomes increasingly challenging to isolate those variables that play the primary role in 
stereospecificity. 
Phenyl ring interactions. 
One set of results from a series of co-crystallisation experiments between MBA and C6~-CH(R)­
C02- with R = CH3, C2Hs and OH, conducted by Brianso14, concluded that anion and cation phenyl 
ring (cp) interactions determined whether or not the diastereomeric salts would separate by 
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crystallisation. Where R = CH3 for example. the dihedral angle between <p-acid and <p-base was 81° 
and 9° for the p and n salts respectively. The p salt was the unstable compound and resolution was 
easier than in the other salts where .these angular differences were less pronounced. Judging from 
Table 4.5 this interpretation clearly fails for our system. 
Table 4. 5 : Dihedral angles between planes containing phenyl rings 
n Salt p Salt (rinf! A) p Salt (rinf! BJ 
cp-GAML'.cp-MBA 48° 44(1 66(' 
cp-GAML'.'. cp-GAMi 80° 62 62\) 
cp-MBAL'.'.cp-MBAi 71° 48 11(1 
cp-GAML'.'.cp-MBAi 54° 78 59° 
(i) -x, y+Yi, -z 
As mentioned previously, the phenyl rings B in the p salt have ''edge on" interactions with C ... C 
distances less than 3A. 
Density and disorder. 
Czugler, Acs er al. 15 find similar disorder in the more soluble salt of MBA co-crystallised with cis-2-
hydroxy-4-cyclopentenylacetic acid. The structure fonns a distinctly more globular aggregate 
whereas the less soluble salt forms " .. a well ordered crystal by assuming a rodlike (linear) orientation. 
via two-dimensional hydrogen bonding between anion and cation". What is implied by the term "well 
ordered"? Clearly X-ray analytical results finding a diffuse electron density in the more soluble salt 
indicate a rtot so "well ordered" crystal: The disorder and lower density of the p salt suggest poor 
recognition between these specific enantiomers of the drug and resolving agent. 
Hydrogen bonding between ionic species (like vs. unlike). 
This was an interesting observation put forward in discussing the differential solubilities of the 
Cinchona (R)- or (S)- Mandelate salts9. In our study similar like vs. unlike hydrogen bonded ions 
occur in the p and n salts respectively. Assuming the species to be partially or completely ionised 
Figure 4.12 schematically compares the distribution of cationic and anionic centres between the two 
modes of stacking. 
0 80° ee0 ee0 . e 
0 80° ee0 ee0 e A 
/s1J.. 
0 ee0 ee0 eeo---e 
B 
Ph _ 
H,NOC, J... ,.co, 
<>-----8 = '-,./ '-,./ @=Ph-< 
NH,+ 
Figure 4. 12: Schematic representation of the charge distribution. A) in the (020) planes 
(d =·10.3A) of then salt. B) in the (lOi) planes (d = 12.0A) of the p salt. The view 
directions are perpendicular to these planes. 
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The p salt has the total charge condensed around 21 axes with the ammonium cations spaced at 3.91A 
intervals. The n salt distributes this charge more evenly throughout layers stacked vertically with 
5.72A being the shortest interval between cationic centres. This more diffuse vs. aggregated charge 
·. 
distribution in the n and p salts respectively once again suggests a favoured vs. disfavoured packing 
mode. 
Potential Function for Hydrogen Bonds 
Table 4.6 shows the geometry of the hydrogen bonded acceptor oxygen atoms around the ammonium 
cation. In the p salt the acceptor oxygens are slightly more puckered around the nitrogen donor and 
are not as ''tetrahedrally arrayed" as in the n salt. 
Table 4.6: Angles about MBA nitrogen 
N Salt 
C-N ... 0(13) 
C-N ... 0(14) 
C-N ... 0(15) 
0(13) .. N .. 0(14) 
0(13) .. N .. 0(15) 








C-N ... 0(13) 
C-N ... 0(13)* 
C-N ... 0(14) 
0(13) .. N .. 0(13)* 
0(13) .. N .. 0(14) 
0(13)* .. N .. 0(14) 








An extensive survey scanning the Crystallographic Structural Database (CSD) investigating 
N-H .... ·O=C hydrogen bonding patterns found the distribution of N-H 0 angles consistent with an 
overall energetic preference for a linear or nearly linear N-H .. 0 arrangement 16• Murray-Rust and 
·. Glusker have also found that hydrogen bonds involving a ketone oxygen atom as the acceptor 
(X-H····O=C<, X = 0,N) prefer an H O=C< angle of about 135° 17. Unfortunately the present 
structures lack hydrogen co-ordinates for the p salt, restricting us to analysing N 0-C geometries 
only. 
Table 4. 7 : Geometry .of acceptor o:-..·ygens surrounding ammonium ca lion 
N Sall P Sall 
Acceptor N 0-C N 0-C ~o t Acceptor N 0-C N o-c-ot 
0(13) 106,1° 2.i' 0(13) 127.8° 3.8° 
0(14) 122.0° 7.6° 0(13)° 118.9° 48.3(' 
0(15) 127.0° 13.50t 0(14) 104.7° 24.4° 
t i.e. angle between the N···o vector and the 0-C-O (carbo:-..·ylate) plane 
t In this case we refer to the 0-C-N (amide) plane 
·With reference to symmetry operator (iv) in Table 4.4 
A quantitative measure of comparative hydrogen bond stabilities is the computation of their potential 
functions as demonstrated by Vedani et al. 18.The authors used a modified Lennard-Jones potential 
function accounting for directionality factors: 
EHs = (A NH A- C'l!JH A)cosk(9o.H A)cosm(XH A·AA - Xo)cos"( roH .A-AA-AB - roo) (I) 
where coefficients A ' and C' depend on various factors such as the donor and acceptor atom type. 
The various symbols are explained in Figure 4.13 
Figure 4.13 : Diagram showing the parameters in equation (1) 
If we now consider directional factors only (i.e. the last three tenns of the equation) we could use the 
values in Table 4. 7 to make a rough comparison of £88 values in the n and p salts for the three 
oxygen atoms listed above. In the absence of hydrogen atom positions the following model was put 
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forward: N-H·· 0 = 180° and rH ... o is constant for all hydrogen bonds involving the ammonium Cation. 
These assumptions are merely made to demonstrate the influence of directionality. Equation (1) 
therefore reduces to: 
/EHB /= K1cosm(XN ... 0-e- Xo)cosn(roN ... 0-e-0 - roo) 
Where K1 is a constant, Xo = 135° and ro0 = 0° for sp2 hybridised carboxyl oxygen atoms. The authors 
derived values m, n = 2 for carboxyl oxygens. Table 4.8 compares the EHB values. 
Table 4.8 : Relative EHs values 
N ... 0(13) 
N ... 0(14) 
N ... 0(15) 
r./ EHB I 





N ... 0(13) 
N ... 0(13)° 
N ... 0(14) 





Calculating EHB values is in actual fact complicated by oxygen atoms accepting hydrogen bonds from 
two donors, as well as some acceptors being carboxylate anions and others embedded in an amide ·. 
moiety. Table 4.8 nevertheless partially succeeds in quantifying energetics of isolated regions in the 
crystal structures to explain the relative salt stabilities. 
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As summarised in Section 1.3.1, several methods by which enantiopure (R)-(-)-Baclofen are 
produced have been reported in ~he literature. No resolution has been reported that makes use of 
simple diastereomeric salt formation. Mostly the reported methods involve multistep syntheses, 
expensive reagents, or small scale chromatographic resolutions only suitable for analysis. 
Resolving the drug via its synthetic precursor GAM has involved no introduction and cleavage !='f 
protecting groups. The resolving agent used for this resolution is readily available at relatively low 
cost. Using 2-amino-l-(p-nitrophenyl)-1,3-propanediol as resolving agent in place of MBA is a 
possibility worthy of investigation. However, the efficiency and purity (99.7% ee) of this resolution 
make it an attractive option for a large scale process and it is indeed presently being tested on 
kilogram scale production at Fine Chemicals Corporation in Cape Town. The inherent problem of 
resolutions allowing for only 50% maximal yield could be surpassed by investigating a suitable 
method by which the unwanted enantiomer is racemized. Cyclodehydrating (SH-)-GAM by 




Treating this prochiral imide with a suitabie base such as NaOH would produce racemic GAM1 
from which the desired R enantiomer could be retrieved by repeating the resolution. 
Counting diastereomeric, kinetic, and chromatographic resolutions, 1527 patents dealing with such 
resolutions were granted between 1967 and 1991. This is only 25% of all publications entered into 
the Chemical Abstracts data base (CA File) over this 25 year period. Yet, few crystal structures of 
salts employed in the resolution of enantiomers have been determined by X-ray crystallography. 
Even fewer reports account for the detem1ination of both diastereomeric salt structures. This study 
therefore contributes to the slowly increasing number of literature reports aimed at quantitative 
explanations for relative diastereomer discrimination. Over the years it has been ascertained that 
aromatic resolving agents are preferred over aliphatic ones and that polyfunctional resolving agents 
are preferred over monofunctional ones since it appears that multiple sites of (nonbonding) 
interactions between the counterions of diastereomeric salts enhance solubility differences2• These 
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kinds of features may only be explained by probing the crystal structures of all possible 
diastereomeric assemblies and analysing the nature of these various interaction sites. 
1. F. Morlacchi, V. Losacco, V. Tortorella, Gazz, Chim. Ital .. l05, (1975), 349. 
2. S.H. Wilen, "Resolving Agents and Resolutions in Organic.Chemistry, Top. 
Stereochem., 6, (197i), 107. 
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Appendix A 
(Crystal structure data for p and n salts of GAM.MBA co-crystals) 
·. 
Table A.l : Atomic coordinates (xl04) and equivalent isotropic displacement parameters 
(A2xl03). U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
(A) P SALT 
x/a y/b z/c U(eq) 
CL(12) 7649 ( 3) 4671 ( 0) 1790( 4) 124 ( 2) 
C(6) 4395( 5) 5435 (23) 1430 ( 8) 65( 2) 
C(7) 4984 ( 5) 3434 (23) 1952 ( 8) 65( 2) 
C(8) 5993( 5) 3195 (23) 2062( 8) 65( 2) 
C(9) 6414 ( 5) 4958 (23) 1652 ( 8) 65( 2) 
C(lO) 5826( 5) 6960 (23) 1132( 8) 65( 2) 
C(ll) 481 7 ( 5) 7198 (23) 1021 ( 8) 65( 2) 
0(15) 1111(11) 6011(69) 131(12) 168 ( 9) 
0(13) 4000 ( 7) ~281 (25) 3992 ( 7) 78( 3) 
0(14) 3862 (10) 9169(28) 2909 (10) 94 ( 4) 
N (16) 971(14) 1953 (79) 50 (15) 161 (14) 
C(l) 3713 ( 9) 7034 (36) 3057(11) 60 ( 4) 
C(2) 3100(10) 5173 (38) 2232 (10) 72 ( 5) 
C(3) 3263 ( 9) 5716 (42) 1239(10) 74 ( 6) 
C(4) 2638(10) 3845 (62) 438 (12) 114 (10) 
C(5) 1506 (13) 4035 (99) 200 (15) 127 (18) 
N(25) 3934 ( 7) •. 1673(28) 4642( 9) 64 ( 3) 
C(l 7) 3353 (15) 3162 (57) 5916(13) 89 ( 7) 
C(l8) 3202(13) 121 7 (36) 5145 (1 7) 79 ( 5) 
C(19)a 2084(20) 763(84) 4457 (25) 127( 4) 
C(20)a 1703(20) 1527(84) 3443 (25) 127 ( 4) 
C(21)a 655(20) 1348(84) 2818 (25) 127( 4) 
C(22)a -11 (20) 403(84) 3208 (25) 127 ( 4) 
C(23)a 370(20) -361(84) 4222 (2~) 127 ( 4) 
C(24)a 1418(20) -179(84) 4846 (25) 127 ( 4) 
C(l9)b 2028(21) 1330(78) 4070 (20) 127 ( 4) 
C(20)b 1606(21) 3631(78) 3727(20) 127 ( 4) 
C(21)b 731 (21) 3855(78) 2813(20) 127 ( 4) 
C(22)b 276(21) 1779 (78) 2243 (20) 127 ( 4) 
C(23)b 697(21) -521 (78) 2585(20) 127 ( 4) 
C(24)b 1573 (21) -746(78) 3499(20) 127 ( 4) 
The letters a and b denote the carbon atoms of cpA and cpB respectively (see Fig. 4.4 page 41). 
The s.o.f.'s of the carbon atoms were refined to 0.52 and 0.48 for cpA and cpB respectively. 
(B) N SALT 
x/a y/b z/c U(eq) 
Cl (12) 5395( 2) 9434 (1) 8428(1) 83 (1) 
0(13) 3604 ( 3) 7149(1) 13560 (3) 49 (1) 
0(14) 5539 ( 3) 6882(1) 11722(2) 47 (1) 
0 (15) 9679 ( 4) 7590(1) 18356(3) 59 (1) 
N(25) -140 ( 4) 6709(1) 10945 (3) 41 (1) 
N(16) 13660 ( 6) 7577 (2) 18488(4) 64 (1) 
C(l) 5506( 4) 7069(1) 1314 7 (3) 35 (1) 
C(2) 7931 ( 4) 7216(1) 14461 (3) 36 (1) 
C(3) 8203 ( 5) 7938(1) 14918 (3) 38(1) 
C(4) 10776 ( 5) 8075(2) 16082 (3) 47 (1) 
C(5) 11335( 6) 7721 (2) 1 7737 (3) 45 (1) 
C(6) 7620 ( 5) 8353(1) 13352 (3) 39(1) 
C(7) 9029 ( 5) 8318(2) 12255(4) 45(1) 
C(8) 8365 ( 6) 8659 (2) 10763(4) 49 (1) 
C(9) 6299 ( 6) 9036 (2) 10371 (4) 52 (1) 
C(lO) 4941 ( 6) 9106(2) 11457 (5) 60(1) 
C(ll) 5599 ( 6) 8764(2) 12941 ~5) 52 (1) 
C(l 7) -310( 8) 5610 (2) 11957(4) 63 (1) 
C(18) 288 ( 5) 6014 (2) 10624(4) 45 (1) 
C(19) -1162 ( 5) 5818 (2) 8853 (4) 45(1) 
C(20) -3564 ( 6) 6014(2) 8130(4) 55(1) 
C(21) -4842 ( 7) 5832(2) 6514(4) 68(1) 
C(22) -3736 ( 9) 5447(2) 5613 (5) 75(1) 
C(23) -1393 (10) 5241 (2) 6320 (5) 79(1) 
C(24) -88 ( 7) 5432(2) 7924 (5) 60(1) 
Table A.2 : Bond Lengths for GAM.MBA [A] 








c (8) -c (9) 
C(7)-C(8) 
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1. 326 (5) 
1.392(4) 








1. 511 (5) 
1.379(5) 
1. 522 (3) 
1. 387 (5) 
1.381 (5) 
1.374 (7) 
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1. 34 (6) 
1.40(2) 
1.40(2) 
1. 40 (2) 
1. 40 (2) 
1.40(2) 
1. 52 (2) 
1. 52 (3) 
1. 57 (2) 
1. 54 (2) 
1.49(3) 
1.39(1) 
1. 53 (2) 
1.40(5) 
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197 1 72 
103 113 































































































































































































































































1 246 223 
1 277 183 
1 265 230 






. 248 149 
24 61 
7 92 764 
1 49 45 
1 296 212 
1 129 84 
1 157 125 
1 33 5 
1 189 170 
1 10 34 











1 126 112 
1 68 59 
1 199 191 
1 66 69 
1 94 100 
1 247 250 
1 297 266 
1 446 451 
1 772 745 
1 434 441 
1 173 197 
1 198 '137 




1 104 88 
1 111 110 
1 74 74 
1 51 51 
1 79 79 
1 62 66 
1 0 44 
1 0 23 
1 45 40 
1 16 45 





136 12 7 
52 4 4 
1 155 147 
1 108 102 
1 73 60 
1 232 265 
~51 246 
301 277 




1 77 69 
1 187 162 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































-7 0 3 
3 -6 ·O 
-5 0 3 
-4 0 3 
-3 0 3 
-2 0 3 
-1 0 
























51 4 4 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6 28 20·29 
6 21 36 8 
6 72 . 106 2 
6 49 6S 3 
6 37 49 3 
6 48 61 3 
6 4 4 50 3 
6 0 44 1 
6 0 15 1 
6 39 33 3 
6 49 65 2 










































































































































































































































6 6 12 
6. 6 0 
6 6 20 
6 6 11 
6 6 21 
0 7 10 
0 4 4 
0 0 
0 7 . 32 
0 S9 
0 76 
0 7 82 
0 7 122 
0 58 
0 7 °195 

































1 7 14 9 
1 7 127 
1 7 234 
1 7 191 
1 7 94 
1 7 2S 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6 4 8 
-10 5 8 
-9 5 8 
-8 5 8 
-7 5 8 
-6 5 8 
-5 5 8 
-4 5 8 
-3 5 8 
-2 5 8 
-1 5 8 
0 5 8 
1 5 8 
2 5 8 







. -10 0 
-9 0 9 
-8 0 9 
-7 0 9 
-6 0 9 
-5 0 9 
-4 0 9 
-3 0 9 
-2 0 9 
-1 0 9 
0 0 9 
1 0 9 
2 0 9 
3 0 9 
4 0 9 
5 0 9 
6 0 9 
7 0 9 
8 0 9 
9 0 9 
-16 1 9 
-15 1 9 
-14 1 9 
-13 1 9 
-12 1 9 
-11 1 9 
-10 1 9 
-9 1 9 
-8 1 9 
-7 1 9 
-6 1 9 
-s 1 9 
-4 1 9 








5 1 9 
6 1 9 
7 1 9 
8 1 9 
9 1 9 
-16 2 9 
-15 2 9 
-14 2 9 
-13 2 9 
-:i:2 2 9 
-11 2 
-10 2 9 
-9 2 9 
-8 2 9 
-7 2 9 
-6 2 9 
-5 2 9 
-4 2 9 
-3 2 9 
-2 2 9 
-1 2 9 
0 2 9 
1 2 9 
2 2 9 
lOFo lOFc 10s 
20 13 10 
9 10 8 
13 23 13 
29 15'28 
16 4 16 
13 18 13 
36 15 5 
0 18 
6 2:3 5 
27 13 26 
0 8 1 
0 22 1 
26 26 26 
13 3 
27 5 26 
0 8 1 
22. 11 22 
21 6 12 
26 9 26 
18 5 18 
15 1 14 
12 4 11 
0 29 1 
13 31 13 
105 96 3 
210 212 
0 34 
96 86 2 
64 69 2 
0 19 1 
109 99 2 
71 4 9· 2 
80 73 2 
133 146 2 
140 146 2 
0 8 1 
73 70 2 
0 8 1 
32 24 4 
0 2 1 
46 47 3 
75 56 2 
20 25 11 
0 18 1 
0 6 1 
18 35 18 
47 45 4 
69 66 2 
4 9 4 5 3 
62 61 2 
70 61 2 
99 80 2 
16 16 15 
18 22 9 
87 92 2 
80 84 1 
36 45 3 
136 123 2 
89 98 2 
18 12 8 
103 81 2 
68 4 9 2 
76 82 2 
4 3 32 
65 65 2 
81 80 2 
55 68 3 
39 26 4 
20 49 19 
58 54 4 
43 39 5 
0 20 1 
41 23 5 
0 32 1 
12 18 12 
0 35 1 
25 38 
0 20 i 
18 4 5 18 
110 113 2 
48 40 
49 56 
23 25 23 
23 2 6 
34 46 
31' 34 4 
72 93 2 
77 82 2 
4l 43 
26 55 6 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2 4 11 
-16 0 12 
-15 0 12 
-14 0 12 
-13 0 12 
-12 0 12 
-11 0 12 
-10 0 12 
-9 0 12 
-8 0 12 
-7 0 12 
-6 0 12 
-5 0 12 
-4 0 12 
-3 0 12 
-2 0 12 
-1 0 12 
0 0 12 
1 0 12 
2 0 12 
0 12 
4 0 12 
5 0 12 








-8 1 12 
-7 1 12 
-6 1 12 
-5 1 12 
-4 1 12 
-3 1 12 
-2 1 12 
-1 12 
0 12 
1 1 12 
2 1 12 
3 1 12 
4 1 12 
5 1 12 
-14 2 12 
-13 2 12 
-12 2 12 
-11 2 12 
-10 2 12 
-9 2 12 
-8 2 12 
-7 2 12 
-6 2 12 
-5 2 12 
-4 2 12 
-3 2 12 
-2 2 12 
-1 2 12 
0 2 12 
1 2 12 
2 2 12 
3 2 12 
4 2 12 
-13 12 
-12 3 12 
-1-1 3 12 
-10 3 12 





-4 3 12 
-3 3 12 
-2 12 
-1 -, 12 
0 3 12 
3 12 
. 2 3 12 
3 12 
-10 12 



































































































































4 9 3 
22 1 















































































































































































































































3 1 13 
4 1 13 
-14 2 13 
-13 2 13 
-12 2 13 
-11 2 13 
-10 2 13 
-9 2 13 
-8 2 13 
-7 2 13 
-6 2 13 
-5 2 13 
-4 2 13 
-3 2 13 
-2 2 13 
-1 2 13 
0 2 13 
1 2 13 
2 2 13 
3 2 13 
-12 3 13 
-11 3 13 
-10 3 13 
-9 3 13 
-8 3 13 
-7 3 13 





-1 3 13 
0 3 13 




-5 4 13 
-4 4 13 
-3 4 13 
-14 0 14 
-13 0 14 
-12 0 14 
-11 0 14 







































































































































-10 0 14 
-9 o· 14 
-8 0 14 
-7 0 14 
-6 0 14 
-5 0 14 
-4 0 14 
-3 0 14 
-2 0 14 
-1 0 14 
0 0 14 
0 14 
2 0 u 
0 14 




-10 1 14 
-9 1 14 
-8 1 14 
-7 1 14 
-6 1 14 
-5 1 14 
-4 1 14 
-3 1 .14 
-2 1 14 




-13 2 14 
-12 2 14 
-11 2 14 
-io " 14 
-9 2 14 
-8 2 14 
-7 2 14 
-6 2 14 
-5 2 14 
-4 2 14 
-3 2 14 
-2 2 14 
-1 2 14 
0 2 14 
1 2 14 


































































































































-11 3 14 
-10 3 14 








-1 3 14 
-13 0 15 
-12 0 15 
-li (I 15 
-10 0 15 
-9 0 15 
-8 0 15 
-7 0 15 
-6 0 15 
-5 0 15 
-4 0 15 
-3 0 15 
-2 0 15 
-1 0 15 
0 0 15 











- 3 15 
-2 15 
-1 15 
0 1 15 
-12 2 15 
-11 2 15 
-10 2 15 
-9 2 15 
-8 2 15 
-7 2 15 



























































































































-6 2 15 
-5 2 is 
-4 2 15 
-3 2 15 
-2 2 15 
-1 2 15 




-4 3 15 
-12 0 16 
-li 0 16 
-10 0 16 
-9 0 16 
-8 0 16 
-7 0 16 
-6 0 16 
-5 0 16 
-4 0 16 
-3 0 16 










-2 1 16 
-9 2 16 
-8 2 16 
-7 2 16 
-6 2 16 
-5 2 16 
-4 2 16 
-9 0 17 
-8 0 17 
-7 0 17 
-6 0 17 


















































































































































































10Fo lOFc 10s 
0 25 25 
0 28 29 
0 23 22 
0 4 3 4 3 
0 45 46 
0 10 12 
0 25 23 
0 22 25 
0 24 28 
0 9 9 
0 12 23 
0 58 56 
0 37 39 
0 4 5 45 
0 47 51 
0 32. 29 
0 21 21 
0 4 
0 87 84 
0 11 7 
0 38 37 
0 38 40 
0 30 27 
0 20 23 
0 23 22 
0 47 50 
0 25 29 
0 69 67 
0 87 84 
0 93 93 
0 58 53-
0 28 26 
0 31 30 
0 90 89 
0 48 53 
0 51 54 
0 53 53 
0 54 56 
0 59 56 
0 65 64 
0 131 131 
0 l8 20 
0 16 14 
0 11 5 
0. 57 56 
0 32 32 
0 101 102 
0 55 59 
0 228 225 
0 130 135 
0 116 113 
0 82 81 
0 30 32 
0 30 34 
0 9 11 
0 91 86 
0 96 96 
0 88 85 
0 53 53 
0 51 48 
0 151 140 
0 122 117 
0 34 35 
0 51 52 
0 9 10 
0 85 81 
0 144 135 
0 51 48 
0 104 106 
0 20 23 
0 52 53 
0 413 417 
0 178 170 
(l 232 229 
0 102 101 
0 76 74 
0 28 27 
0 32 33 
0 235 236 
0 187 181 
0 76 74 
0 66 69 
0 76 71 
0 42 42 
0 562' 572 
0 340 340 
0 174 173 
0 61 55 
0 30 32 













































































































































































































































































































































































































h lOFo lOFc 10s 
3-1 7 28 
4-17' 1 5 
-5-16 1 29 
-4-16 1 28 
-3-16 1 80 
-2-16 1 0 
-1-16 1 67 
0-16 1 58 
1-16 1 15 
2-16 1 66 
3-16 1 31 
4-16 1 46 










-5-14 1 44 
-4-14 1 20 
-3-14 1 53 
-2-14 1 79 
-1-14 1 91 
0-14 1 124 
1-14 1 100 
2-14 1 22 
3-14 1 65 
4-14 . 1 , 36 































3-11 1 59 
4-11 1 85 
5-11 1 39 
-6-10 1 28 















































































































































































































































































































































































































































































































































































































































































































































































































































































-6 -9 2 
-5 -9 2 
-4 -9 2 
-3 -9 2 
-2 -9 2 
-1 -9 2 
0 -9 2 
1 -9 2 
2 -9 2 
3 -9 2 
4 -9 2 
5 -9 2 
-6 -8 2 
-5 -8 2 
-4 -8 2 
-3 -8 2 
-2 -8 2 
-1 -8' 2 
0 -8 2 





























52 50 1 
61 62 1 





109 110 1 
2B 31 1 
3B 39 1 
39 3B 1 
51 51 1 
48 47 1 
226 222 1 
175 174 1 
72 73 1 
222 222 1 
83 77 1 
53 53 1 






148 147 1 
91 91 1 
91 8 9 1 . 
22 21 1 
36 35 1 
4 7 3 
50 49 1 






201 200 1 
36 33 ], 
9 14 3 
64 5B 1 
19 20 1 
73 74 1 
87 90 1 
52 4B 1 
107 103 1 
202 200 1 
163 160 1 
i30 129 1 
48 4B .1 
7 11 4 
50 4B 1 
56 5B 1 
25 23 1 
14 14 2 




357 357 1 
332 326 1 
125 131 1 
110 107' 1 
65 64 1 
36 37 1 
10 14 10 
41 3B 1 
69 70 1 
47 47 1 
97 98 1 
368 361 1 
115 108 
38 38 
113 107 1 
43 41 1 
61 62 1 
36 33 1 
35 34 1 
2B 26 1 
89 87 1 
159 15i. 1 
99 103 1 
179 184 1 
231 227 1 































































































































































































































































































































































































































3 24 23 
3 '19 19 






. 44 4 3 
37 38 
3 37 38 
3 54 54 
3 27 27 
3 19 19 
3 21 25 
3 58 56 
3 26 25 
3 31 31 
3 33 34 
3 21 22 
3 64 63 
3 2B 27 
3 17 17 
3 25 2B 
















3 110 109 
3 114 114 
3 72 72 
3 43 43 
3 67 64 
3 71 72 
3 0 33 
3 B4 88 
3 60 60 
3 B2 B6 
3: 145 142 
3 11 12 
3 59 60 
3 5 6 
3 16 17 
3 18 20 
3 79 77 
3 11 20 
3 67 65 
3 42 42 
3 B7 B7 
3 125 126 
3 39 36 
3 41 3B 
3 4 6 4 9 
3 21 2 3 
3 67 70 
142 140 





2 3 20 
71 71 
69 69 
3 B6 B5 
3 203 199 
3 160 162 
3 116 118 
3 204 206 
3 24 26 
3 39 39 
























































































































3 148 140 
3 40 40 
3 156 154 
3 4B 50 
82 83 
3 4 5 4 4 
3 0 8 
3 21 20 
3 13 13 
3 79 83 
3 213 216 
3 llB llB 
3 227 227 
3 112 106 
3 146 147 
3 9B 95 
3 57 56 
3 21 20 
3 91 91 
3 41 47 
3 47 51 
3 50 53 









3 123 129 




3 71 76 
3 111 108 
3 111 112 
19 19 
27 25 
3 46 46 
3 105 112 
3 133 141 
3 57 56 
3 172 174 
3 32 33 
3 208 197 
3 72 75 
3 llB 119 
3 133 12B 
3 75 77 
3 45 45 
3 0 9 
3 10 20 
3 54 53 
3 31 35 
3 153 143 
3 253 24B 
3 393 3BB 
3 220 211 
3 ·15 7 15 7 
B4 Bi 
66 67 
3 19 17 
3 4 5 4 7 
3 7B 79 
3 16 19 
86 B5 













3 194 189 
3 279 266 
3 347 341 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(I -9 5 
1 -9 5 
-9 5 
3 -9 5 
-9 5 
-6 -8 5 
-5 -8 5 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table A. 8 Observed and calculated structure· factors for n salt 
h k 
3 -8 6 
-6 -7 6 
-5 -7 6 
-4 -7 6 
-3 -7 6 
-2 -7 6 
-1 -7 6 
0 -7 6 
1 -7 6 
2 -7 6 
3 -7 6 
-6 -6 6 
-5 -6 6 
-4 -6 6 
-3 -6 6 
-2 -6 6 
-1 -6 6 
0 -6 6 
1 -6 6 
2 -6 6 
3 -6 6 
-6 -5 6 
-5 -5 6 
-4 -5 6 
-3 -5 6 
-2 -5 6 
-1 -5 6 
0 -5 6 
1 -5 6 
2 -5 6 
3 -5 6 
-6 -4 6 
-5 -4 6 
-4 -4 6 
-3 -4 6 
-2 -4 6 
-1 -4 6 
0 -4 6 
1 -4 6 
2 -4 6 
3 -4 6 
-6 -3 6 
-5 -3 6 
-4 -3 6 
-3 -3 6 
-2 -3 6 
-1 -3 6 
0 -3 6 
1 -3 6 
2 -3 6 
3 -3 6 
-6 -2 6 
-5 -2 6 
-4 -2 6 
-3 -2 6 
-2 -2 6 
-1 -2 6 
0 -2 6 
1 -2 6 
2 -2 6 
3 -2 6 
-6 -1 6 
-5 -1 6 
-4 -1 6 
-3 -1 6 
-2 -1 6 
-1 -1 6 
0 -1 6 
1 -1 6 
2 -1 6 
3 -1 6 





70 72 1 
71 66 1 
76 77 1 
48 47 1 
166 171 1 
51 50 1 
54 57 1 
67 65 1 
19 14 1 
46 44 1 
96 95 1 
100 100 1 
54 54 1 
118 117 1 
30 34 1 
98 98 1 
31 31 1 
56 57 1 
44 44 1 
94 98 1 
140 141 1 
165 163 1 
135 137 1 
45 45 1 
55 58 
22 20 
11 12 11 · 
48 45 1 
46 48 1 
0 15 1 
27 35 1 
186 185 1 





47 43 1 
14 12 2 
55 50 1 
67 64 1 
128 127 1 
95 96 1 
73 72 1 
50 49 1 
118 119 1 

















30 26 1 
7 5· 77 1 
25 23 1 
23 21 1 
h 
-6 0 6 
-5 ·o 6 
-4 0 6 
-3 0 6 
-2 0 6 
-1 0 6 
0 0 6 
1 0 6 
2 0 6 






















































-4 -8 7 
-3 -8 7 




2 -8 7 
-5 -7 7 


























































































































































































-2 -2 7 
-1 -2 7 
0 -2 7 
1 -2 7 
2 -2 
3 -2 7 










-6 . 0 
-5 0 7 








lOE'o lOFc 10s 
2.1 2 9 


















































































































-4 -9 8 
-3 -9 
-.2 -9 
-1 -9 8 
0 -9 8 
1 -9 8 
-4 -8 8 
-3 -8 8 
-2 -8 8 









1 -7 8 
-5 -6 8 
-4 -6 8 
-3 -6 8 
-2 -6 8 
-1 -6 8 
0 -6 8 
1 -6 8 
-5 -5 8 
-4 -5 8 
-3 -5 8 
-2 -5 8 
-1 -5 8 
0 -5 8 









-5 -3 8 
-4 -3 8 
-3 -3 8 
-2 -3 8 
-1 -3 8 
0 -3 
1 -3 8 
2 -3 8 
-5 -2 8 



















































































































































































































































































































































































Table A.5: Hydrogen atom coordinates 
(A 2xl03) for GAM.MBA (n salt) 
(xl04) and isotropic displacement parameters 
x/a y/D :z/c U.t•o 
H(251) -1636 (53) 6803(18) 11201 (45) 53 ( 9) 
H(252) -266(60) 6990(14) 10023 (35) 37 ( 7) 
H(253) 1063 (70) 6871 (25) 11884 (44) 80 (13) 
H(3) 7028 ( 5) 8044( l) 15523 ( 3) 35 ( 7) 
H(lO) 3594 ( 6) 9381( 2) 11198 ( 5) 71 ( 4) 
H(20) -4324 ( 6) 6270 ( 2) 8742 ( 4) 71 ( 4) 
H(l61) 14007(78) 7463 (23) 19495 (59) 64 ( 8) 
H(l62) 14782 (69) 7700(20) l 7899 (49) 64 ( 8) 
H(8) 9310 ( 6) 8634 ( 2) 10033( 4) 71 ( 4) 
H(7) 10429 ( 5) 8062 ( 2) 12528( 4) 71 ( 4) 
H(2A) 9262 ( 4) 7085 ( l) 14037 ( 3) 57 ( 5) 
H(2B) 8049( 4) 6965( l) 15463 ( 3) 57 ( 5) 
H(ll) 4676 ( 6) 8807 ( 2) 13680 ( 5) 71 ( 4) 
H(4A) 11964 ( 5) 7949 ( 2) 15521 ( 3) 57 ( 5) 
H(4B) 10948 ( 5) 8536 ( 2) 1.6296 ( 3) 57 ( 5) 
H(l 71) 655 ( 8) 5755 ( 2) 13046 ( 4) 63 ( 7) 
H (172) 51 ( 8) 5164 ( 2) 11813( 4) 63 ( 7) 
H (l 73) -2015( 8) 5655 ( 2) 11860( 4) 63( 7) 
H(l8) 2030 ( 5) 5959 ( 2) 10741 ( 4) 44 ( 8) 
H(24) 1527 ( 7) 5299 ( 2) 8381 ( 5) 71 ( 4) 
H(21) -6445 ( 7) 5971 ( 2) 6038 ( 4) 71 ( 4) 
H(23) -667(10) 4969( 2) 5719 ( 5) 71 ( 4) 
H (22) -4586 ( 9) 5327 ( 2) 4521 ( 5) 71 ( 4) 
Table A. 6 Torsion angles (degrees) with e.s.d. 'sin parentheses 
(Right-Hand Rule,Klyne & Prelog.(1960).Experientia,16,521) 
(e.s.d.'s, following Stanford & Waser, Acta Cryst.(1972).A28,213) 
N Salt P Salt 
(253) - N(25) - c (18) - H (18) -44 ( 3) C(ll) - C(6) - C(3) - C(4) 105( 2) 
(252) - N(25) - C(18) - H (18) 80( 2) C(7) - C(6) ·- C(3) - ~(4) -72( 2) 
(251) - N(25) - c (18) - H (18) -162 ( 2) C(ll) - C(6) - C(3) - C(2) -137 ( 1) 
(253) - N(25) - c (18) - c (19) -163( 3) C(7) - C(6) - C(3) - C(2) 46( 2) 
(252) - N(25) - c (18) - c (19) -39( 2) C(3) - C(6) - c (11) - C(lO) -177( 1) (251) - N(25) - c (18) - c (19) 80( 2) C(7) - C(6) - C(ll) - c (10) 0( 2) (253) - N (25) - c (18) - C(l 7) 73( 3) C(ll) - C(6) - C(7) - C(8) 0( 2) (252) - N(25) - c (18) - c (1 7) -163( 2) C(3) - C(6) - C(7) - C(8) 177( 1) (251) - N(25) - c (18) - C(l 7) ::,,-. -45( 2) C(6) - C(7) - C(8) - C(9) 0( 2) (2) - C(3) - C(4) - H(4A) 58.9( 4) C(7) - C(8) - C(9) - CL(12) 180( 1) (6) - C(3) - C(4) - H(4A) -64.5( 4) C(7) - C(8) - C(9) - C(lO) 0( 2) (3) - C(3) - C(4) - H(4A), 176.8( 4) C(8) - C(9) - c (10) - C(ll) ·o < 2) (2) - C(3) - C(4) - H(4B) 176.2( 3) CL (12) - C(9) - c (10) - C(ll) -180( 1) (6) - C(3) - C(4) - H (4B) 52.8( 4) C(9) - C(lO) - C(ll) - C(6) 0( 2) (3) - C(3) - C(4) - H(4B) -65.9( 5) 0(14) - C(l) - C(2) - C(3) 34 ( 2) (2) - C(3) - C(4) - C(5) -62.4( 3) .. 0(13) - C(l) - C(2) - C(3) -153( 1) (6) - C(3) - C(4) - C(5) 174.1 ( 3) C(l) - C(2) - C(3) - C(6) 62( 2) (3) - C(3) - C(4) - C(5) 55.5( 4) C(l) - C(2) - C(3) - C(4) -180( 1) (6) - C(3) - C(2) - H (2A) 71.5( 4) C(2) - C(3) - C(4) - C(5) 60( 2) (3) - C(3) - C(2) - H(2A) -170.2( 4) C(6) - C(3) - C(4) - C(5) -179( 2) (6) - C(3) - C(2) - H (2B) -170.7( 3) C(3) - C(4) - C(5) - N(16) -141( 3) (3) - C(3) - C(2) - H(2B) -52. 4 ( 4) C(3) - C(4) - C(5) - 0 (15) 40( 4) (4) - C(3) - C(2) - C(l) -173.4( 2) C(l 7) - C(18) - C(19)b - C::(20)b 34 ( 4) (6) - C(3) - C(2) - C(l) -49.6( 3) N(25) - C(l8) - C(19)b - C(20)b -83( 3) (3) - C(3) - C(2) - C(l) 68.7( 4) C(l 7) - C(18) - C(19)b - C(24)b -153( 3) (3) - C(3) - C(6) - C(7) 178.7( 3) N(25) - c (18) - C(19)b - C(24)b 90( 3) (3) - C(3) - C(6) - C(ll) -3.8( 5) C(l 7) - C(18) - C(19)a - C(20)a 108( 3) 2) - C(3) - C(6) - C(ll) 114. 5 ( 3) N(25) - c (18) - C(19)a - C(20)a -20( 4) (2) - C(3) - C(6) - C(7) -63.0( 4) C(l 7) - c (18) - C(19)a - C(24)a -66( 4) 4) - C(3) - C(6) - c (11) -122.4( 3) N(25) - c (18) - C(19)a - C(24)a 166( 3) 4) - C(3) - C(6) - C(7) 60.0( 4) C(18) - C(19)a - C(24)a - C(23)a 174 ( 3) 4) - C(3) - C(2) - H(2B) 65.5( 4) C(18) - C(19)a - C(20)a - C(21)a -174 ( 3) 4) - c (3)_ - C(2) - H(2A) -52.3( 4) C(20)a - C(19)a - C(24)a - C(23)a 0( 6) 13) - C(l) - C(2) - C(3) -65.8( 3) C(24)a - C(19)a - C(20)a - C(21)a 0( 6) 14) - C(l) - C(2) - C(3) 113.6( 3) C(20)a - C(21)a - C(22)a - C(23)a 0( 6) 14) - C(l) - C(2) - H (2A) -7.6( 4) C(22)a - C(23)a - C(24)a - C(19)a 0( 6) 13) - C(l) - C(2) - H (2A) 173.0 ( 3) C(18) - C(19)b - C(24)b - C(23)b -173( 3) 14) - C(<l) - C(2) - H(2B) -125.3( 3) C(18) - C(19)b - C(20)b - C(21)b 173( 3) 13) - C(l) - C(2) - H(2B) 55.3( 4) C(20)b - C(19)b - C(24)b - C(23)b 0( 5) 3) - C(6) - C(ll) - H(ll) 5.0( 6) C(24)b - C(19)b - C(20)b - C(21)b 0( 5) 3) - C(6) - c (11) - c (10) .:.175.0( 3) C(19)b - C(20)b - C(21)b - C(22)b 0( 5) 3) - C(6) - C(7) - H(7) -5.3( 5) C(20)b - C(2l)b - C(22)b - C(23)b 0( 5) 3) - C(6) - C(7) - C(8) 174.7( 3) C(21)b - C(22)b - C(23)b - C(24)b 0( 5) 7) - C(6) - C(ll) - H(ll) -177. 4 ( 4) C(22)b - C(23)b - C(24)b - C(l9)b 0( 5) 7) - C(6) - C(ll) - c (10) 2.6( 5) 
11) - C(6) - C(7) - C(8) -2.9( 5) 
11) - C(6) - C(7) - H(7) 177.1( 4) 
n' salt continued .... 
(16) - C(5) - C(4) - C(3) 151.7( 3) 
(15) - C(5) - C(4) - H (4A) -151. 2 ( 4) 
(15) - C(5) - C(4) - H (4B) 91.5( 4) 
(15) - C(5) - N(16) - H (161) -12 ( 4) 
(15) - C(5) - N(16) - H (162) 180( 3) 
(16) - C(5) - C(4) - H(4A) 30.4 ( 5) 
(16) - C(5) - C(4) - H(4B) -87.0( 4) 
(4) - C(5) - N(16) - H(162) -2 ( 3) 
(4) - C(5) - N(16) - H(l61) 167( 4) 
(11) - c (10) - C(9) - CL(12) 176.6( 3) 
(10) - c (10) - C(9) - CL(l2) -3.4( 7) 
(10) - C(lO) - C(ll) - C(6) -179.6( 5) 
(9) - c (10) - c (11) - C(6) 0. 4 ( 6) 
(11) - c (10) - C(9) - C(8) -3.3( 6) 
(10) - c (10) - C(9) - C(8) 176. 7 ( 5) 
i(lO) - C(lO) - C(ll) - H(ll) 0.4 ( 8) 
(9) - C(lO) - C(ll) - H(ll) -179.6( 5) 
(19) - C(20) - c (21) - H (21) -179.3( 5) 
(20) - C(20) - C(21) - H(21) 0.8( 8) 
(19) -. C(20) - c (21) - c (22) 0.7( 6) 
(20) - C(20) - - C(21) - C(22) -179.2( 5) 
(20) - C(20) - C(19) - C(18) :-0.4( 6) 
(20) - c (20) - C(19) - C(24) 179.3( 5) 
(21) - C(20) - C(l9) - C(24) -0.6( 6) 
(21) - c (20) - C(l9) - C(l8) 179.6( 4) 
(20) - c (19) - c (18) - N(25) -42. 2 ( 4) 
(20) - C(19) - C(24) - H(24) 179.3( 5) 
(20) - c (19) - C(24) - c (23) -0.7( 6) 
(20) - C(l9) - c (18) - H (18) -160.6( 4) 
(20) - C(l9) - C(l8) - c (1 7) 79.8( 4) 
(24) - C(l9) - c (18) - N(25) 138.1 ( 3) 
(18) - c (19) - c (24) - H(24) -1.0 ( 7) 
(18) - c (19) - C(24) - C(23) 179.0( 4) 
(24) . - C(19) - C(18) - C(l 7) -99.9( 4) 
(24) - C(l9) - c (18) - H (18) 19.7( 5) 
(7) - C(8) - c (9). - CL(l2) -176, 8 ( 3) 0 
(8) - C(8) - C(9) - CL(12) 3.2 ( 6) 
(7) - C(8) - C(9) - c (10) 3.1 ( 6) 
(8) - C(8) - C(9) - C(lO) -176.9( 4) 
(8) - C(8) - C(7) - C(6) -179.9( 4) 
(9) - C(8) - C(7) - c (6) 0 .1 ( 5) 
(8) - C(8) - C(7) - H(7) 0 .1 ( 7) 
(9) - C(8) - C(7) - H(7) -179.9( 4) 
(173) ~- C(l 7) - c (18) - N(25) :,:.; 63.6( 5) 
(172) - c (1 7) - C(l8) - N(25) -176.4( 4) 
(171) - c (1 7) - c (18) - N(25) -56.4 ( 5) 
(173) - C(l 7) - c (18) - C(19) -60.0( 5) 
(172) - c (1 7) - c (18) - C(l9) 60.0( 5) 
(171) - c (1 7) - c (18) - c (19) -180.0( 4) 
(173) - c (1 7) - c (18) - H(l8) -179.6( 5) 
(172) - C(l 7) - c (18) - H (18) -59.6( 6) 
(171) - C(l7) - c (18) - H (18) 60.4( 6) 
(19) - C(24) - C(23) - H(23) -178.0( 6) 
(19) - C(24) - C(23) - C(22) 2.0( 7) 
(24) - C(24) - C(23) - H (23) 2.0( 9) 
(24) - C(24) - c (23) - C(22) -178.0( 5) 
(20) C(21) C(22) H (22) -179.5( 6) 
(20) - C(21) - C(22) - c (23) 0.5( 7) 
21) - C(21) - C(22) - H(22) 0.5( 9) 
(21) - C(21) - c (22) - c (23) -179.5( 6) 
24) - c (23) - c (22) - C(21) -1.9( 8) 
23) - C(23) - C(22) - C(21) 178.1( 6) 
24) - c (23) - c (22) - H(22) 178.1 ( 6) 
23) - c (23) - C(22) - H (22) -2( 1) 
